Healthcare Contract Research Organizations Market By Services (Clinical Monitoring & Trial Management, Data and Project Management, Medical Writing & Publishing, Regulatory Services, Patient Recruitment & Retention, Safety & Pharmacovigilance, Statistical Review & Reporting, Consulting Services, and Others); By Development Phase ( Planning & Discovery, Phase I, Phase II, Phase III, Phase IV, Post Launch); By Organization Size (Small & Medium Organization, Large Organization); By Therapeutic Area (Cardiovascular, Oncology & Hematology, Infectious Disease, Neurology, Rare Diseases, Respiratory, Urology, Cell & Gene Therapy, Women’s Health, Vaccine Development, Others); By End-User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Company, Others); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia(Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia) Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029

Report ID :AMI-1040 | Category : Healthcare | Published Date : February, 2022 | Pages : 420 | Format :PDF

Industry Trends

The global healthcare contract research organizations market is being driven by the increasing investments in research and development activities as a result of the rising demand for novel drugs. In 2020, pharmaceutical industries spent nearly USD 200 billion globally for research and development. With the changing R&D landscape, a large part of R&D is being outsourced to the contract research organizations with an aim to reduce cost, which is thereby propelling the healthcare contract research organizations market growth. According to the data published in a study, the outsourced services’ expenditure share in the worldwide pharmaceutical market stood at 37.7% in 2018 and is expected to increase to over 49% in 2023. The rising complexity of drug development process has increased the duration and cost of bringing a drug into the market. Also, the synthesis and formulation of next-generation biologics, such as ADCs, gene therapy, cell therapy, and peptides, are highly complex. Contract research organizations align their capabilities for the development of these innovative therapies. Moreover, the contract research outsourcing solutions provide cutting-edge services due to which government agencies choose to delegate projects to them, allowing the market to grow.

The industry faced a significant impact during the COVID-19 pandemic. The outbreak of coronavirus increased the focus on finding the vaccines against virus, which impacted significantly the development of other drugs and vaccines. In the United States, during the peak period of the pandemic, COVID 19 vaccines and treatments accounted for 30% of all the trials. Also, the pandemic effect on oncology patients was high. In Europe, many sponsors, collaborators, contract research organizations announced disruptions in their planned and ongoing clinical trials. Suspended and delayed clinical trials along with postponed initiations have been highlighted as major reasons for the disruptions. Globally, there were 826 organizations that reported specific disrupted clinical trials in the public domain of which 8.2% were located in the UK, 5% in France. This had a negative impact on the healthcare contract research organizations market in Europe. However, the market participants have experienced significant demand post the reversal of stringent lockdown measures.

In terms of revenue, the global healthcare contract research organizations market was valued at US$ 40,348. Mn in 2020 growing at a CAGR of 8.8% over the forecast period (2021 – 2029). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.

Global Healthcare Contract Research Organizations Market Revenue & Forecast, (US$ Million), 2015 – 2029

Service Outlook:

Based on services, the healthcare contract research organizations market has been segmented into clinical monitoring and trial management, data and project management, medical writing and publishing, regulatory services, patient recruitment and retention, safety and pharmacovigilance, statistical review and reporting, consulting services and others. The clinical monitoring and trial management dominated the healthcare contract research organizations market owing to rising number of clinical trials. The rising need for personalized drugs, biologics and increasing incidences of chronic disease are the major factors contributing to the growth of the segment. The outburst of COVID 19 developed the need of vaccines thereby, adding fuelling segment’s growth. According to the data published by the World Health Organization (WHO) COVID candidate vaccine landscape, more than 80 COVID 19 vaccines were tested in clinical trials and over 180 were in pre-clinical stages. Moreover, the increasing investments by public and private sector is impelling the market growth. However, regulatory services segment is anticipated to witness a fast growth over a forecast period. This growth is attributed towards the increasing need of drug approvals.

Development Phase Outlook:

Based on development phase, the healthcare contract research organizations market has been segmented into planning and discovery, Phase I, Phase II, Phase III, Phase IV, and post-launch. Phase III dominated the global market owing to the increasing demand for evaluation of new treatments. Moreover, Phase III trials are most expensive and take a longer time. According to a study, the average cost of Phase III ranged from USD 11.5 million to USD 52.9 million. The planning and discovery phase is anticipated to witness lucrative growth over the forecast period owing to increasing R&D costs and stringent regulatory requirements. The leading CROs are focusing on the development in the field of planning and discovery phase, thereby contributing towards the segment’s growth.

Organization Size Outlook:

Based on organization size, the global healthcare contract research organizations market has been bifurcated into small and medium organizations and large organizations. The small and medium-size organization accounted for a prominent market share owing to the changing trends in contract research organizations. These organizations are entering the complex drug development process without significant investment in capital equipment thereby, witnessing growth.

Therapeutic Area Outlook:

Based on therapeutic area, the healthcare contract research organizations market is segmented into cardiovascular, oncology and hematology, infectious diseases, neurology, rare disease, respiratory, urology, cell and gene therapy, women's health, vaccine development, and others. The oncology segment dominated the market in 2020 owing to the increase of cancer patients around the world. As per a study, in 2020, nearly 10 million deaths were witnessed due to cancer worldwide. The rising demand for new therapies to treat cancer is impelling the segment’s growth. Cardiovascular therapeutic area is witnessing growth owing to increase in the number of cardiac patients. Cardiovascular diseases are among the most prominent causes of deaths globally. As per a study, an estimated 17.9 million died from cardiovascular disease in 2019, representing 32% of all global deaths.

End-User Outlook:

On the basis of end-user segment, the healthcare contract research organizations market is classified into pharmaceutical companies, biotechnology companies, medical device companies, and others. The pharmaceutical companies dominated the market in 2020 owing to a rise in research and development expenditure. As per a study, in 2019, the pharmaceutical industry spent USD 186 billion on research and development and by 2026, expenditures are expected to reach a total of over USD 230 billion.

Region Outlook:

North America emerged as the largest regional market in healthcare contract research organizations market in 2020. This growth is attributed to the presence of well-established pharmaceutical and biotechnology industries. The increasing investment in biologics and drug discovery is another factor responsible for regional growth. Moreover, the increasing clinical trials and outsourcing in the region are contributing towards the market growth. As per a study, in 2019, 31% of all clinical drug trials were started in North America. Asia Pacific is witnessing lucrative growth and is anticipated to witness highest growth rate over the forecast period. An increasing number of trials and proliferation of various diseases in the region are propelling the market growth. The increasing healthcare expenditure and significant technological advancement are contributing to the growth of healthcare contract research organizations market in the region.

Competitive Landscape

The report provides both, qualitative and quantitative research of the global healthcare contract research organizations market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysis in the report. For each company, the report studies their global presence, competitors, service offerings, and specification amongst others.

Some of the key players operating in the global healthcare contract research organizations market are:

Advanced Clinical
BioAgile Therapeutics Pvt. Ltd.
Charles River Laboratories International, Inc.
Clinipace
CTI Clinical Trial & Consulting
Frontage Labs
ICON plc
IQVIA Inc.
Parexel International Corporation
Syneos Health
Thermo Fisher Scientific Inc.
Worldwide Clinical Trials
WuXi AppTec
Other Market Participants

Click on image to enlarge

Global Healthcare Contract Research Organization Market:

By Services:
- Clinical Monitoring & Trial Management
- Data and Project Management
- Medical Writing and Publishing
- Regulatory Services
- Patient Recruitment & Retention
- Safety and Pharmacovigilance
- Statistical Review & Reporting
- Consulting Services
- Others
By Development Phase:
- Planning & Discovery
- Phase I
- Phase II
- Phase III
- Phase IV
- Post Launch
By Organization Size:
- Small and Medium Organizations
- Large Organizations
By Therapeutic Areas:
- Cardiovascular
- Oncology and Hematology
- Infectious Diseases
- Neurology
- Rare Diseases
- Respiratory
- Urology
- Cell & Gene Therapy
- Women’s Health
- Vaccine Development
- Others
By End Users
- Pharmaceutical Companies
- Biotechnology Companies
- Medical Device Companies
- Others
By Region
- North America
  - U.S.
  - Canada
  - Mexico
  - Rest of North America
- Europe
  - France
  - The UK
  - Spain
  - Germany
  - Italy
  - Nordic Countries
    - Denmark
    - Finland
    - Iceland
    - Sweden
    - Norway
  - Benelux Union
    - Belgium
    - The Netherlands
    - Luxembourg
  - Rest of Europe
- Asia Pacific
  - China
  - Japan
  - India
  - New Zealand
  - Australia
  - South Korea
  - Southeast Asia
    - Indonesia
    - Thailand
    - Malaysia
    - Singapore
    - Rest of Southeast Asia
  - Rest of Asia Pacific
- Middle East & Africa
  - Saudi Arabia
  - UAE
  - Egypt
  - Kuwait
  - South Africa
  - Rest of Middle East & Africa
- Latin America
  - Brazil
  - Argentina
  - Rest of Latin America

Table of Contents

1. Market Scope

1.1. Market Segmentation

1.2. Years Considered

1.2.1. Historic Years: 2015 - 2019

1.2.2. Base Year: 2020

1.2.3. Forecast Years: 2021 – 2029

2. Key Target Audiences

3. Research Methodology

3.1. Primary Research

3.1.1. Research Questionnaire

3.1.2. Global Percentage Breakdown

3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)

3.2. Secondary Research

3.2.1. Paid Databases

3.2.2. Secondary Sources

3.3. Market Size Estimates

3.3.1. Top-Down Approach

3.3.2. Bottom-Up Approach

3.4. Data Triangulation Methodology

3.5. Research Assumptions

4. Recommendations and Insights from AMI’s Perspective**

5. Holistic Overview of Healthcare Contract Research Organizations Market

6. Market Synopsis: Healthcare Contract Research Organizations Market

7. Healthcare Contract Research Organizations Market Analysis: Qualitative Perspective

7.1. Introduction

7.1.1. Product Definition

7.1.2. Industry Development

7.2. Market Dynamics

7.2.1. Drivers

7.2.2. Restraints

7.2.3. Opportunities

7.3. Trends in Healthcare Contract Research Organizations Market

7.4. Market Determinants Radar Chart

7.5. Macro-Economic and Micro-Economic Indicators: Healthcare Contract Research Organizations Market

7.6. Porter’s Five Force Analysis

7.7. Impact of Covid-19 on Healthcare Contract Research Organizations Market

8. Global Healthcare Contract Research Organizations Market Analysis and Forecasts, 2021 – 2029

8.1. Overview

8.1.1. Global Healthcare Contract Research Organizations Market Revenue (US$ Mn)

8.2. Global Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

8.2.1. Clinical Monitoring and Trial Management

8.2.1.1. Definition

8.2.1.2. Market Estimation and Penetration, 2015 - 2020

8.2.1.3. Market Forecast, 2021 - 2029

8.2.1.4. Compound Annual Growth Rate (CAGR)

8.2.1.5. Regional Bifurcation

8.2.1.5.1. North America

8.2.1.5.1.1. Market Estimation, 2015 - 2020

8.2.1.5.1.2. Market Forecast, 2021 - 2029

8.2.1.5.2. Europe

8.2.1.5.2.1. Market Estimation, 2015 - 2020

8.2.1.5.2.2. Market Forecast, 2021 - 2029

8.2.1.5.3. Asia Pacific

8.2.1.5.3.1. Market Estimation, 2015 - 2020

8.2.1.5.3.2. Market Forecast, 2021 - 2029

8.2.1.5.4. Middle East and Africa

8.2.1.5.4.1. Market Estimation, 2015 - 2020

8.2.1.5.4.2. Market Forecast, 2021 - 2029

8.2.1.5.5. Latin America

8.2.1.5.5.1. Market Estimation, 2015 - 2020

8.2.1.5.5.2. Market Forecast, 2021 - 2029

8.2.2. Data and Project Management

8.2.2.1. Definition

8.2.2.2. Market Estimation and Penetration, 2015 - 2020

8.2.2.3. Market Forecast, 2021 - 2029

8.2.2.4. Compound Annual Growth Rate (CAGR)

8.2.2.5. Regional Bifurcation

8.2.2.5.1. North America

8.2.2.5.1.1. Market Estimation, 2015 - 2020

8.2.2.5.1.2. Market Forecast, 2021 - 2029

8.2.2.5.2. Europe

8.2.2.5.2.1. Market Estimation, 2015 - 2020

8.2.2.5.2.2. Market Forecast, 2021 - 2029

8.2.2.5.3. Asia Pacific

8.2.2.5.3.1. Market Estimation, 2015 - 2020

8.2.2.5.3.2. Market Forecast, 2021 - 2029

8.2.2.5.4. Middle East and Africa

8.2.2.5.4.1. Market Estimation, 2015 - 2020

8.2.2.5.4.2. Market Forecast, 2021 - 2029

8.2.2.5.5. Latin America

8.2.2.5.5.1. Market Estimation, 2015 - 2020

8.2.2.5.5.2. Market Forecast, 2021 - 2029

8.2.3. Medical Writing and Publishing

8.2.3.1. Definition

8.2.3.2. Market Estimation and Penetration, 2015 - 2020

8.2.3.3. Market Forecast, 2021 - 2029

8.2.3.4. Compound Annual Growth Rate (CAGR)

8.2.3.5. Regional Bifurcation

8.2.3.5.1. North America

8.2.3.5.1.1. Market Estimation, 2015 - 2020

8.2.3.5.1.2. Market Forecast, 2021 - 2029

8.2.3.5.2. Europe

8.2.3.5.2.1. Market Estimation, 2015 - 2020

8.2.3.5.2.2. Market Forecast, 2021 - 2029

8.2.3.5.3. Asia Pacific

8.2.3.5.3.1. Market Estimation, 2015 - 2020

8.2.3.5.3.2. Market Forecast, 2021 - 2029

8.2.3.5.4. Middle East and Africa

8.2.3.5.4.1. Market Estimation, 2015 - 2020

8.2.3.5.4.2. Market Forecast, 2021 - 2029

8.2.3.5.5. Latin America

8.2.3.5.5.1. Market Estimation, 2015 - 2020

8.2.3.5.5.2. Market Forecast, 2021 - 2029

8.2.4. Regulatory Services

8.2.4.1. Definition

8.2.4.2. Market Estimation and Penetration, 2015 - 2020

8.2.4.3. Market Forecast, 2021 - 2029

8.2.4.4. Compound Annual Growth Rate (CAGR)

8.2.4.5. Regional Bifurcation

8.2.4.5.1. North America

8.2.4.5.1.1. Market Estimation, 2015 - 2020

8.2.4.5.1.2. Market Forecast, 2021 - 2029

8.2.4.5.2. Europe

8.2.4.5.2.1. Market Estimation, 2015 - 2020

8.2.4.5.2.2. Market Forecast, 2021 - 2029

8.2.4.5.3. Asia Pacific

8.2.4.5.3.1. Market Estimation, 2015 - 2020

8.2.4.5.3.2. Market Forecast, 2021 - 2029

8.2.4.5.4. Middle East and Africa

8.2.4.5.4.1. Market Estimation, 2015 - 2020

8.2.4.5.4.2. Market Forecast, 2021 - 2029

8.2.4.5.5. Latin America

8.2.4.5.5.1. Market Estimation, 2015 - 2020

8.2.4.5.5.2. Market Forecast, 2021 - 2029

8.2.5. Patient Recruitment and Retention

8.2.5.1. Definition

8.2.5.2. Market Estimation and Penetration, 2015 - 2020

8.2.5.3. Market Forecast, 2021 - 2029

8.2.5.4. Compound Annual Growth Rate (CAGR)

8.2.5.5. Regional Bifurcation

8.2.5.5.1. North America

8.2.5.5.1.1. Market Estimation, 2015 - 2020

8.2.5.5.1.2. Market Forecast, 2021 - 2029

8.2.5.5.2. Europe

8.2.5.5.2.1. Market Estimation, 2015 - 2020

8.2.5.5.2.2. Market Forecast, 2021 - 2029

8.2.5.5.3. Asia Pacific

8.2.5.5.3.1. Market Estimation, 2015 - 2020

8.2.5.5.3.2. Market Forecast, 2021 - 2029

8.2.5.5.4. Middle East and Africa

8.2.5.5.4.1. Market Estimation, 2015 - 2020

8.2.5.5.4.2. Market Forecast, 2021 - 2029

8.2.5.5.5. Latin America

8.2.5.5.5.1. Market Estimation, 2015 - 2020

8.2.5.5.5.2. Market Forecast, 2021 - 2029

8.2.6. Safety and Pharmacovigilance

8.2.6.1. Definition

8.2.6.2. Market Estimation and Penetration, 2015 - 2020

8.2.6.3. Market Forecast, 2021 - 2029

8.2.6.4. Compound Annual Growth Rate (CAGR)

8.2.6.5. Regional Bifurcation

8.2.6.5.1. North America

8.2.6.5.1.1. Market Estimation, 2015 - 2020

8.2.6.5.1.2. Market Forecast, 2021 - 2029

8.2.6.5.2. Europe

8.2.6.5.2.1. Market Estimation, 2015 - 2020

8.2.6.5.2.2. Market Forecast, 2021 - 2029

8.2.6.5.3. Asia Pacific

8.2.6.5.3.1. Market Estimation, 2015 - 2020

8.2.6.5.3.2. Market Forecast, 2021 - 2029

8.2.6.5.4. Middle East and Africa

8.2.6.5.4.1. Market Estimation, 2015 - 2020

8.2.6.5.4.2. Market Forecast, 2021 - 2029

8.2.6.5.5. Latin America

8.2.6.5.5.1. Market Estimation, 2015 - 2020

8.2.6.5.5.2. Market Forecast, 2021 - 2029

8.2.7. Statistical Review and Reporting

8.2.7.1. Definition

8.2.7.2. Market Estimation and Penetration, 2015 - 2020

8.2.7.3. Market Forecast, 2021 - 2029

8.2.7.4. Compound Annual Growth Rate (CAGR)

8.2.7.5. Regional Bifurcation

8.2.7.5.1. North America

8.2.7.5.1.1. Market Estimation, 2015 - 2020

8.2.7.5.1.2. Market Forecast, 2021 - 2029

8.2.7.5.2. Europe

8.2.7.5.2.1. Market Estimation, 2015 - 2020

8.2.7.5.2.2. Market Forecast, 2021 - 2029

8.2.7.5.3. Asia Pacific

8.2.7.5.3.1. Market Estimation, 2015 - 2020

8.2.7.5.3.2. Market Forecast, 2021 - 2029

8.2.7.5.4. Middle East and Africa

8.2.7.5.4.1. Market Estimation, 2015 - 2020

8.2.7.5.4.2. Market Forecast, 2021 - 2029

8.2.7.5.5. Latin America

8.2.7.5.5.1. Market Estimation, 2015 - 2020

8.2.7.5.5.2. Market Forecast, 2021 - 2029

8.2.8. Consulting Services

8.2.8.1. Definition

8.2.8.2. Market Estimation and Penetration, 2015 - 2020

8.2.8.3. Market Forecast, 2021 - 2029

8.2.8.4. Compound Annual Growth Rate (CAGR)

8.2.8.5. Regional Bifurcation

8.2.8.5.1. North America

8.2.8.5.1.1. Market Estimation, 2015 - 2020

8.2.8.5.1.2. Market Forecast, 2021 - 2029

8.2.8.5.2. Europe

8.2.8.5.2.1. Market Estimation, 2015 - 2020

8.2.8.5.2.2. Market Forecast, 2021 - 2029

8.2.8.5.3. Asia Pacific

8.2.8.5.3.1. Market Estimation, 2015 - 2020

8.2.8.5.3.2. Market Forecast, 2021 - 2029

8.2.8.5.4. Middle East and Africa

8.2.8.5.4.1. Market Estimation, 2015 - 2020

8.2.8.5.4.2. Market Forecast, 2021 - 2029

8.2.8.5.5. Latin America

8.2.8.5.5.1. Market Estimation, 2015 - 2020

8.2.8.5.5.2. Market Forecast, 2021 - 2029

8.2.9. Others

8.2.9.1. Definition

8.2.9.2. Market Estimation and Penetration, 2015 - 2020

8.2.9.3. Market Forecast, 2021 - 2029

8.2.9.4. Compound Annual Growth Rate (CAGR)

8.2.9.5. Regional Bifurcation

8.2.9.5.1. North America

8.2.9.5.1.1. Market Estimation, 2015 - 2020

8.2.9.5.1.2. Market Forecast, 2021 - 2029

8.2.9.5.2. Europe

8.2.9.5.2.1. Market Estimation, 2015 - 2020

8.2.9.5.2.2. Market Forecast, 2021 - 2029

8.2.9.5.3. Asia Pacific

8.2.9.5.3.1. Market Estimation, 2015 - 2020

8.2.9.5.3.2. Market Forecast, 2021 - 2029

8.2.9.5.4. Middle East and Africa

8.2.9.5.4.1. Market Estimation, 2015 - 2020

8.2.9.5.4.2. Market Forecast, 2021 - 2029

8.2.9.5.5. Latin America

8.2.9.5.5.1. Market Estimation, 2015 - 2020

8.2.9.5.5.2. Market Forecast, 2021 - 2029

8.3. Key Segment for Channeling Investments

8.3.1. By Services

9. Global Healthcare Contract Research Organizations Market Analysis and Forecasts, 2021 – 2029

9.1. Overview

9.2. Global Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

9.2.1. Planning and Discovery

9.2.1.1. Definition

9.2.1.2. Market Estimation and Penetration, 2015 - 2020

9.2.1.3. Market Forecast, 2021 - 2029

9.2.1.4. Compound Annual Growth Rate (CAGR)

9.2.1.5. Regional Bifurcation

9.2.1.5.1. North America

9.2.1.5.1.1. Market Estimation, 2015 - 2020

9.2.1.5.1.2. Market Forecast, 2021 - 2029

9.2.1.5.2. Europe

9.2.1.5.2.1. Market Estimation, 2015 - 2020

9.2.1.5.2.2. Market Forecast, 2021 - 2029

9.2.1.5.3. Asia Pacific

9.2.1.5.3.1. Market Estimation, 2015 - 2020

9.2.1.5.3.2. Market Forecast, 2021 - 2029

9.2.1.5.4. Middle East and Africa

9.2.1.5.4.1. Market Estimation, 2015 - 2020

9.2.1.5.4.2. Market Forecast, 2021 - 2029

9.2.1.5.5. Latin America

9.2.1.5.5.1. Market Estimation, 2015 - 2020

9.2.1.5.5.2. Market Forecast, 2021 - 2029

9.2.2. Phase I

9.2.2.1. Definition

9.2.2.2. Market Estimation and Penetration, 2015 - 2020

9.2.2.3. Market Forecast, 2021 - 2029

9.2.2.4. Compound Annual Growth Rate (CAGR)

9.2.2.5. Regional Bifurcation

9.2.2.5.1. North America

9.2.2.5.1.1. Market Estimation, 2015 - 2020

9.2.2.5.1.2. Market Forecast, 2021 - 2029

9.2.2.5.2. Europe

9.2.2.5.2.1. Market Estimation, 2015 - 2020

9.2.2.5.2.2. Market Forecast, 2021 - 2029

9.2.2.5.3. Asia Pacific

9.2.2.5.3.1. Market Estimation, 2015 - 2020

9.2.2.5.3.2. Market Forecast, 2021 - 2029

9.2.2.5.4. Middle East and Africa

9.2.2.5.4.1. Market Estimation, 2015 - 2020

9.2.2.5.4.2. Market Forecast, 2021 - 2029

9.2.2.5.5. Latin America

9.2.2.5.5.1. Market Estimation, 2015 - 2020

9.2.2.5.5.2. Market Forecast, 2021 - 2029

9.2.3. Phase II

9.2.3.1. Definition

9.2.3.2. Market Estimation and Penetration, 2015 - 2020

9.2.3.3. Market Forecast, 2021 - 2029

9.2.3.4. Compound Annual Growth Rate (CAGR)

9.2.3.5. Regional Bifurcation

9.2.3.5.1. North America

9.2.3.5.1.1. Market Estimation, 2015 - 2020

9.2.3.5.1.2. Market Forecast, 2021 - 2029

9.2.3.5.2. Europe

9.2.3.5.2.1. Market Estimation, 2015 - 2020

9.2.3.5.2.2. Market Forecast, 2021 - 2029

9.2.3.5.3. Asia Pacific

9.2.3.5.3.1. Market Estimation, 2015 - 2020

9.2.3.5.3.2. Market Forecast, 2021 - 2029

9.2.3.5.4. Middle East and Africa

9.2.3.5.4.1. Market Estimation, 2015 - 2020

9.2.3.5.4.2. Market Forecast, 2021 - 2029

9.2.3.5.5. Latin America

9.2.3.5.5.1. Market Estimation, 2015 - 2020

9.2.3.5.5.2. Market Forecast, 2021 - 2029

9.2.4. Phase III

9.2.4.1. Definition

9.2.4.2. Market Estimation and Penetration, 2015 - 2020

9.2.4.3. Market Forecast, 2021 - 2029

9.2.4.4. Compound Annual Growth Rate (CAGR)

9.2.4.5. Regional Bifurcation

9.2.4.5.1. North America

9.2.4.5.1.1. Market Estimation, 2015 - 2020

9.2.4.5.1.2. Market Forecast, 2021 - 2029

9.2.4.5.2. Europe

9.2.4.5.2.1. Market Estimation, 2015 - 2020

9.2.4.5.2.2. Market Forecast, 2021 - 2029

9.2.4.5.3. Asia Pacific

9.2.4.5.3.1. Market Estimation, 2015 - 2020

9.2.4.5.3.2. Market Forecast, 2021 - 2029

9.2.4.5.4. Middle East and Africa

9.2.4.5.4.1. Market Estimation, 2015 - 2020

9.2.4.5.4.2. Market Forecast, 2021 - 2029

9.2.4.5.5. Latin America

9.2.4.5.5.1. Market Estimation, 2015 - 2020

9.2.4.5.5.2. Market Forecast, 2021 - 2029

9.2.5. Phase IV

9.2.5.1. Definition

9.2.5.2. Market Estimation and Penetration, 2015 - 2020

9.2.5.3. Market Forecast, 2021 - 2029

9.2.5.4. Compound Annual Growth Rate (CAGR)

9.2.5.5. Regional Bifurcation

9.2.5.5.1. North America

9.2.5.5.1.1. Market Estimation, 2015 - 2020

9.2.5.5.1.2. Market Forecast, 2021 - 2029

9.2.5.5.2. Europe

9.2.5.5.2.1. Market Estimation, 2015 - 2020

9.2.5.5.2.2. Market Forecast, 2021 - 2029

9.2.5.5.3. Asia Pacific

9.2.5.5.3.1. Market Estimation, 2015 - 2020

9.2.5.5.3.2. Market Forecast, 2021 - 2029

9.2.5.5.4. Middle East and Africa

9.2.5.5.4.1. Market Estimation, 2015 - 2020

9.2.5.5.4.2. Market Forecast, 2021 - 2029

9.2.5.5.5. Latin America

9.2.5.5.5.1. Market Estimation, 2015 - 2020

9.2.5.5.5.2. Market Forecast, 2021 - 2029

9.2.6. Post Launch

9.2.6.1. Definition

9.2.6.2. Market Estimation and Penetration, 2015 - 2020

9.2.6.3. Market Forecast, 2021 - 2029

9.2.6.4. Compound Annual Growth Rate (CAGR)

9.2.6.5. Regional Bifurcation

9.2.6.5.1. North America

9.2.6.5.1.1. Market Estimation, 2015 - 2020

9.2.6.5.1.2. Market Forecast, 2021 - 2029

9.2.6.5.2. Europe

9.2.6.5.2.1. Market Estimation, 2015 - 2020

9.2.6.5.2.2. Market Forecast, 2021 - 2029

9.2.6.5.3. Asia Pacific

9.2.6.5.3.1. Market Estimation, 2015 - 2020

9.2.6.5.3.2. Market Forecast, 2021 - 2029

9.2.6.5.4. Middle East and Africa

9.2.6.5.4.1. Market Estimation, 2015 - 2020

9.2.6.5.4.2. Market Forecast, 2021 - 2029

9.2.6.5.5. Latin America

9.2.6.5.5.1. Market Estimation, 2015 - 2020

9.2.6.5.5.2. Market Forecast, 2021 - 2029

9.3. Key Segment for Channeling Investments

9.3.1. By Development Phase

10. Global Healthcare Contract Research Organizations Market Analysis and Forecasts, 2021 – 2029

10.1. Overview

10.2. Global Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

10.2.1. Small and Medium Organizations

10.2.1.1. Definition

10.2.1.2. Market Estimation and Penetration, 2015 - 2020

10.2.1.3. Market Forecast, 2021 - 2029

10.2.1.4. Compound Annual Growth Rate (CAGR)

10.2.1.5. Regional Bifurcation

10.2.1.5.1. North America

10.2.1.5.1.1. Market Estimation, 2015 - 2020

10.2.1.5.1.2. Market Forecast, 2021 - 2029

10.2.1.5.2. Europe

10.2.1.5.2.1. Market Estimation, 2015 - 2020

10.2.1.5.2.2. Market Forecast, 2021 - 2029

10.2.1.5.3. Asia Pacific

10.2.1.5.3.1. Market Estimation, 2015 - 2020

10.2.1.5.3.2. Market Forecast, 2021 - 2029

10.2.1.5.4. Middle East and Africa

10.2.1.5.4.1. Market Estimation, 2015 - 2020

10.2.1.5.4.2. Market Forecast, 2021 - 2029

10.2.1.5.5. Latin America

10.2.1.5.5.1. Market Estimation, 2015 - 2020

10.2.1.5.5.2. Market Forecast, 2021 - 2029

10.2.2. Large Organizations

10.2.2.1. Definition

10.2.2.2. Market Estimation and Penetration, 2015 - 2020

10.2.2.3. Market Forecast, 2021 - 2029

10.2.2.4. Compound Annual Growth Rate (CAGR)

10.2.2.5. Regional Bifurcation

10.2.2.5.1. North America

10.2.2.5.1.1. Market Estimation, 2015 - 2020

10.2.2.5.1.2. Market Forecast, 2021 - 2029

10.2.2.5.2. Europe

10.2.2.5.2.1. Market Estimation, 2015 - 2020

10.2.2.5.2.2. Market Forecast, 2021 - 2029

10.2.2.5.3. Asia Pacific

10.2.2.5.3.1. Market Estimation, 2015 - 2020

10.2.2.5.3.2. Market Forecast, 2021 - 2029

10.2.2.5.4. Middle East and Africa

10.2.2.5.4.1. Market Estimation, 2015 - 2020

10.2.2.5.4.2. Market Forecast, 2021 - 2029

10.2.2.5.5. Latin America

10.2.2.5.5.1. Market Estimation, 2015 - 2020

10.2.2.5.5.2. Market Forecast, 2021 - 2029

10.3. Key Segment for Channeling Investments

10.3.1. By Organization Size

11. Global Healthcare Contract Research Organizations Market Analysis and Forecasts, 2021 – 2029

11.1. Overview

11.2. Global Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

11.2.1. Cardiovascular

11.2.1.1. Definition

11.2.1.2. Market Estimation and Penetration, 2015 - 2020

11.2.1.3. Market Forecast, 2021 - 2029

11.2.1.4. Compound Annual Growth Rate (CAGR)

11.2.1.5. Regional Bifurcation

11.2.1.5.1. North America

11.2.1.5.1.1. Market Estimation, 2015 - 2020

11.2.1.5.1.2. Market Forecast, 2021 - 2029

11.2.1.5.2. Europe

11.2.1.5.2.1. Market Estimation, 2015 - 2020

11.2.1.5.2.2. Market Forecast, 2021 - 2029

11.2.1.5.3. Asia Pacific

11.2.1.5.3.1. Market Estimation, 2015 - 2020

11.2.1.5.3.2. Market Forecast, 2021 - 2029

11.2.1.5.4. Middle East and Africa

11.2.1.5.4.1. Market Estimation, 2015 - 2020

11.2.1.5.4.2. Market Forecast, 2021 - 2029

11.2.1.5.5. Latin America

11.2.1.5.5.1. Market Estimation, 2015 - 2020

11.2.1.5.5.2. Market Forecast, 2021 - 2029

11.2.2. Oncology and Hematology

11.2.2.1. Definition

11.2.2.2. Market Estimation and Penetration, 2015 - 2020

11.2.2.3. Market Forecast, 2021 - 2029

11.2.2.4. Compound Annual Growth Rate (CAGR)

11.2.2.5. Regional Bifurcation

11.2.2.5.1. North America

11.2.2.5.1.1. Market Estimation, 2015 - 2020

11.2.2.5.1.2. Market Forecast, 2021 - 2029

11.2.2.5.2. Europe

11.2.2.5.2.1. Market Estimation, 2015 - 2020

11.2.2.5.2.2. Market Forecast, 2021 - 2029

11.2.2.5.3. Asia Pacific

11.2.2.5.3.1. Market Estimation, 2015 - 2020

11.2.2.5.3.2. Market Forecast, 2021 - 2029

11.2.2.5.4. Middle East and Africa

11.2.2.5.4.1. Market Estimation, 2015 - 2020

11.2.2.5.4.2. Market Forecast, 2021 - 2029

11.2.2.5.5. Latin America

11.2.2.5.5.1. Market Estimation, 2015 - 2020

11.2.2.5.5.2. Market Forecast, 2021 - 2029

11.2.3. Infectious Diseases

11.2.3.1. Definition

11.2.3.2. Market Estimation and Penetration, 2015 - 2020

11.2.3.3. Market Forecast, 2021 - 2029

11.2.3.4. Compound Annual Growth Rate (CAGR)

11.2.3.5. Regional Bifurcation

11.2.3.5.1. North America

11.2.3.5.1.1. Market Estimation, 2015 - 2020

11.2.3.5.1.2. Market Forecast, 2021 - 2029

11.2.3.5.2. Europe

11.2.3.5.2.1. Market Estimation, 2015 - 2020

11.2.3.5.2.2. Market Forecast, 2021 - 2029

11.2.3.5.3. Asia Pacific

11.2.3.5.3.1. Market Estimation, 2015 - 2020

11.2.3.5.3.2. Market Forecast, 2021 - 2029

11.2.3.5.4. Middle East and Africa

11.2.3.5.4.1. Market Estimation, 2015 - 2020

11.2.3.5.4.2. Market Forecast, 2021 - 2029

11.2.3.5.5. Latin America

11.2.3.5.5.1. Market Estimation, 2015 - 2020

11.2.3.5.5.2. Market Forecast, 2021 - 2029

11.2.4. Neurology

11.2.4.1. Definition

11.2.4.2. Market Estimation and Penetration, 2015 - 2020

11.2.4.3. Market Forecast, 2021 - 2029

11.2.4.4. Compound Annual Growth Rate (CAGR)

11.2.4.5. Regional Bifurcation

11.2.4.5.1. North America

11.2.4.5.1.1. Market Estimation, 2015 - 2020

11.2.4.5.1.2. Market Forecast, 2021 - 2029

11.2.4.5.2. Europe

11.2.4.5.2.1. Market Estimation, 2015 - 2020

11.2.4.5.2.2. Market Forecast, 2021 - 2029

11.2.4.5.3. Asia Pacific

11.2.4.5.3.1. Market Estimation, 2015 - 2020

11.2.4.5.3.2. Market Forecast, 2021 - 2029

11.2.4.5.4. Middle East and Africa

11.2.4.5.4.1. Market Estimation, 2015 - 2020

11.2.4.5.4.2. Market Forecast, 2021 - 2029

11.2.4.5.5. Latin America

11.2.4.5.5.1. Market Estimation, 2015 - 2020

11.2.4.5.5.2. Market Forecast, 2021 - 2029

11.2.5. Rare Diseases

11.2.5.1. Definition

11.2.5.2. Market Estimation and Penetration, 2015 - 2020

11.2.5.3. Market Forecast, 2021 - 2029

11.2.5.4. Compound Annual Growth Rate (CAGR)

11.2.5.5. Regional Bifurcation

11.2.5.5.1. North America

11.2.5.5.1.1. Market Estimation, 2015 - 2020

11.2.5.5.1.2. Market Forecast, 2021 - 2029

11.2.5.5.2. Europe

11.2.5.5.2.1. Market Estimation, 2015 - 2020

11.2.5.5.2.2. Market Forecast, 2021 - 2029

11.2.5.5.3. Asia Pacific

11.2.5.5.3.1. Market Estimation, 2015 - 2020

11.2.5.5.3.2. Market Forecast, 2021 - 2029

11.2.5.5.4. Middle East and Africa

11.2.5.5.4.1. Market Estimation, 2015 - 2020

11.2.5.5.4.2. Market Forecast, 2021 - 2029

11.2.5.5.5. Latin America

11.2.5.5.5.1. Market Estimation, 2015 - 2020

11.2.5.5.5.2. Market Forecast, 2021 - 2029

11.2.6. Respiratory

11.2.6.1. Definition

11.2.6.2. Market Estimation and Penetration, 2015 - 2020

11.2.6.3. Market Forecast, 2021 - 2029

11.2.6.4. Compound Annual Growth Rate (CAGR)

11.2.6.5. Regional Bifurcation

11.2.6.5.1. North America

11.2.6.5.1.1. Market Estimation, 2015 - 2020

11.2.6.5.1.2. Market Forecast, 2021 - 2029

11.2.6.5.2. Europe

11.2.6.5.2.1. Market Estimation, 2015 - 2020

11.2.6.5.2.2. Market Forecast, 2021 - 2029

11.2.6.5.3. Asia Pacific

11.2.6.5.3.1. Market Estimation, 2015 - 2020

11.2.6.5.3.2. Market Forecast, 2021 - 2029

11.2.6.5.4. Middle East and Africa

11.2.6.5.4.1. Market Estimation, 2015 - 2020

11.2.6.5.4.2. Market Forecast, 2021 - 2029

11.2.6.5.5. Latin America

11.2.6.5.5.1. Market Estimation, 2015 - 2020

11.2.6.5.5.2. Market Forecast, 2021 - 2029

11.2.7. Urology

11.2.7.1. Definition

11.2.7.2. Market Estimation and Penetration, 2015 - 2020

11.2.7.3. Market Forecast, 2021 - 2029

11.2.7.4. Compound Annual Growth Rate (CAGR)

11.2.7.5. Regional Bifurcation

11.2.7.5.1. North America

11.2.7.5.1.1. Market Estimation, 2015 - 2020

11.2.7.5.1.2. Market Forecast, 2021 - 2029

11.2.7.5.2. Europe

11.2.7.5.2.1. Market Estimation, 2015 - 2020

11.2.7.5.2.2. Market Forecast, 2021 - 2029

11.2.7.5.3. Asia Pacific

11.2.7.5.3.1. Market Estimation, 2015 - 2020

11.2.7.5.3.2. Market Forecast, 2021 - 2029

11.2.7.5.4. Middle East and Africa

11.2.7.5.4.1. Market Estimation, 2015 - 2020

11.2.7.5.4.2. Market Forecast, 2021 - 2029

11.2.7.5.5. Latin America

11.2.7.5.5.1. Market Estimation, 2015 - 2020

11.2.7.5.5.2. Market Forecast, 2021 - 2029

11.2.8. Cell and Gene Therapy

11.2.8.1. Definition

11.2.8.2. Market Estimation and Penetration, 2015 - 2020

11.2.8.3. Market Forecast, 2021 - 2029

11.2.8.4. Compound Annual Growth Rate (CAGR)

11.2.8.5. Regional Bifurcation

11.2.8.5.1. North America

11.2.8.5.1.1. Market Estimation, 2015 - 2020

11.2.8.5.1.2. Market Forecast, 2021 - 2029

11.2.8.5.2. Europe

11.2.8.5.2.1. Market Estimation, 2015 - 2020

11.2.8.5.2.2. Market Forecast, 2021 - 2029

11.2.8.5.3. Asia Pacific

11.2.8.5.3.1. Market Estimation, 2015 - 2020

11.2.8.5.3.2. Market Forecast, 2021 - 2029

11.2.8.5.4. Middle East and Africa

11.2.8.5.4.1. Market Estimation, 2015 - 2020

11.2.8.5.4.2. Market Forecast, 2021 - 2029

11.2.8.5.5. Latin America

11.2.8.5.5.1. Market Estimation, 2015 - 2020

11.2.8.5.5.2. Market Forecast, 2021 - 2029

11.2.9. Women’s Health

11.2.9.1. Definition

11.2.9.2. Market Estimation and Penetration, 2015 - 2020

11.2.9.3. Market Forecast, 2021 - 2029

11.2.9.4. Compound Annual Growth Rate (CAGR)

11.2.9.5. Regional Bifurcation

11.2.9.5.1. North America

11.2.9.5.1.1. Market Estimation, 2015 - 2020

11.2.9.5.1.2. Market Forecast, 2021 - 2029

11.2.9.5.2. Europe

11.2.9.5.2.1. Market Estimation, 2015 - 2020

11.2.9.5.2.2. Market Forecast, 2021 - 2029

11.2.9.5.3. Asia Pacific

11.2.9.5.3.1. Market Estimation, 2015 - 2020

11.2.9.5.3.2. Market Forecast, 2021 - 2029

11.2.9.5.4. Middle East and Africa

11.2.9.5.4.1. Market Estimation, 2015 - 2020

11.2.9.5.4.2. Market Forecast, 2021 - 2029

11.2.9.5.5. Latin America

11.2.9.5.5.1. Market Estimation, 2015 - 2020

11.2.9.5.5.2. Market Forecast, 2021 - 2029

11.2.10. Vaccine Development

11.2.10.1. Definition

11.2.10.2. Market Estimation and Penetration, 2015 - 2020

11.2.10.3. Market Forecast, 2021 - 2029

11.2.10.4. Compound Annual Growth Rate (CAGR)

11.2.10.5. Regional Bifurcation

11.2.10.5.1. North America

11.2.10.5.1.1. Market Estimation, 2015 - 2020

11.2.10.5.1.2. Market Forecast, 2021 - 2029

11.2.10.5.2. Europe

11.2.10.5.2.1. Market Estimation, 2015 - 2020

11.2.10.5.2.2. Market Forecast, 2021 - 2029

11.2.10.5.3. Asia Pacific

11.2.10.5.3.1. Market Estimation, 2015 - 2020

11.2.10.5.3.2. Market Forecast, 2021 - 2029

11.2.10.5.4. Middle East and Africa

11.2.10.5.4.1. Market Estimation, 2015 - 2020

11.2.10.5.4.2. Market Forecast, 2021 - 2029

11.2.10.5.5. Latin America

11.2.10.5.5.1. Market Estimation, 2015 - 2020

11.2.10.5.5.2. Market Forecast, 2021 - 2029

11.2.11. Others

11.2.11.1. Definition

11.2.11.2. Market Estimation and Penetration, 2015 - 2020

11.2.11.3. Market Forecast, 2021 - 2029

11.2.11.4. Compound Annual Growth Rate (CAGR)

11.2.11.5. Regional Bifurcation

11.2.11.5.1. North America

11.2.11.5.1.1. Market Estimation, 2015 - 2020

11.2.11.5.1.2. Market Forecast, 2021 - 2029

11.2.11.5.2. Europe

11.2.11.5.2.1. Market Estimation, 2015 - 2020

11.2.11.5.2.2. Market Forecast, 2021 - 2029

11.2.11.5.3. Asia Pacific

11.2.11.5.3.1. Market Estimation, 2015 - 2020

11.2.11.5.3.2. Market Forecast, 2021 - 2029

11.2.11.5.4. Middle East and Africa

11.2.11.5.4.1. Market Estimation, 2015 - 2020

11.2.11.5.4.2. Market Forecast, 2021 - 2029

11.2.11.5.5. Latin America

11.2.11.5.5.1. Market Estimation, 2015 - 2020

11.2.11.5.5.2. Market Forecast, 2021 - 2029

11.3. Key Segment for Channeling Investments

11.3.1. By Therapeutic Areas

12. Global Healthcare Contract Research Organizations Market Analysis and Forecasts, 2021 – 2029

12.1. Overview

12.2. Global Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

12.2.1. Pharmaceutical Companies

12.2.1.1. Definition

12.2.1.2. Market Estimation and Penetration, 2015 - 2020

12.2.1.3. Market Forecast, 2021 - 2029

12.2.1.4. Compound Annual Growth Rate (CAGR)

12.2.1.5. Regional Bifurcation

12.2.1.5.1. North America

12.2.1.5.1.1. Market Estimation, 2015 - 2020

12.2.1.5.1.2. Market Forecast, 2021 - 2029

12.2.1.5.2. Europe

12.2.1.5.2.1. Market Estimation, 2015 - 2020

12.2.1.5.2.2. Market Forecast, 2021 - 2029

12.2.1.5.3. Asia Pacific

12.2.1.5.3.1. Market Estimation, 2015 - 2020

12.2.1.5.3.2. Market Forecast, 2021 - 2029

12.2.1.5.4. Middle East and Africa

12.2.1.5.4.1. Market Estimation, 2015 - 2020

12.2.1.5.4.2. Market Forecast, 2021 - 2029

12.2.1.5.5. Latin America

12.2.1.5.5.1. Market Estimation, 2015 - 2020

12.2.1.5.5.2. Market Forecast, 2021 - 2029

12.2.2. Biotechnology Companies

12.2.2.1. Definition

12.2.2.2. Market Estimation and Penetration, 2015 - 2020

12.2.2.3. Market Forecast, 2021 - 2029

12.2.2.4. Compound Annual Growth Rate (CAGR)

12.2.2.5. Regional Bifurcation

12.2.2.5.1. North America

12.2.2.5.1.1. Market Estimation, 2015 - 2020

12.2.2.5.1.2. Market Forecast, 2021 - 2029

12.2.2.5.2. Europe

12.2.2.5.2.1. Market Estimation, 2015 - 2020

12.2.2.5.2.2. Market Forecast, 2021 - 2029

12.2.2.5.3. Asia Pacific

12.2.2.5.3.1. Market Estimation, 2015 - 2020

12.2.2.5.3.2. Market Forecast, 2021 - 2029

12.2.2.5.4. Middle East and Africa

12.2.2.5.4.1. Market Estimation, 2015 - 2020

12.2.2.5.4.2. Market Forecast, 2021 - 2029

12.2.2.5.5. Latin America

12.2.2.5.5.1. Market Estimation, 2015 - 2020

12.2.2.5.5.2. Market Forecast, 2021 - 2029

12.2.3. Medical Device Companies

12.2.3.1. Definition

12.2.3.2. Market Estimation and Penetration, 2015 - 2020

12.2.3.3. Market Forecast, 2021 - 2029

12.2.3.4. Compound Annual Growth Rate (CAGR)

12.2.3.5. Regional Bifurcation

12.2.3.5.1. North America

12.2.3.5.1.1. Market Estimation, 2015 - 2020

12.2.3.5.1.2. Market Forecast, 2021 - 2029

12.2.3.5.2. Europe

12.2.3.5.2.1. Market Estimation, 2015 - 2020

12.2.3.5.2.2. Market Forecast, 2021 - 2029

12.2.3.5.3. Asia Pacific

12.2.3.5.3.1. Market Estimation, 2015 - 2020

12.2.3.5.3.2. Market Forecast, 2021 - 2029

12.2.3.5.4. Middle East and Africa

12.2.3.5.4.1. Market Estimation, 2015 - 2020

12.2.3.5.4.2. Market Forecast, 2021 - 2029

12.2.3.5.5. Latin America

12.2.3.5.5.1. Market Estimation, 2015 - 2020

12.2.3.5.5.2. Market Forecast, 2021 - 2029

12.2.4. Others

12.2.4.1. Definition

12.2.4.2. Market Estimation and Penetration, 2015 - 2020

12.2.4.3. Market Forecast, 2021 - 2029

12.2.4.4. Compound Annual Growth Rate (CAGR)

12.2.4.5. Regional Bifurcation

12.2.4.5.1. North America

12.2.4.5.1.1. Market Estimation, 2015 - 2020

12.2.4.5.1.2. Market Forecast, 2021 - 2029

12.2.4.5.2. Europe

12.2.4.5.2.1. Market Estimation, 2015 - 2020

12.2.4.5.2.2. Market Forecast, 2021 - 2029

12.2.4.5.3. Asia Pacific

12.2.4.5.3.1. Market Estimation, 2015 - 2020

12.2.4.5.3.2. Market Forecast, 2021 - 2029

12.2.4.5.4. Middle East and Africa

12.2.4.5.4.1. Market Estimation, 2015 - 2020

12.2.4.5.4.2. Market Forecast, 2021 - 2029

12.2.4.5.5. Latin America

12.2.4.5.5.1. Market Estimation, 2015 - 2020

12.2.4.5.5.2. Market Forecast, 2021 - 2029

12.3. Key Segment for Channeling Investments

12.3.1. By End Users

13. North America Healthcare Contract Research Organizations Market Analysis and Forecasts, 2021 - 2029

13.1. Overview

13.1.1. North America Healthcare Contract Research Organizations Market Revenue (US$ Mn)

13.2. North America Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

13.2.1. Clinical Monitoring and Trial Management

13.2.2. Data and Project Management

13.2.3. Medical Writing and Publishing

13.2.4. Regulatory Services

13.2.5. Patient Recruitment and Retention

13.2.6. Safety and Pharmacovigilance

13.2.7. Statistical Review and Reporting

13.2.8. Consulting Services

13.2.9. Others

13.3. North America Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

13.3.1. Planning and Discovery

13.3.2. Phase I

13.3.3. Phase II

13.3.4. Phase III

13.3.5. Phase IV

13.3.6. Post Launch

13.4. North America Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

13.4.1. Small and Medium Organizations

13.4.2. Large Organizations

13.5. North America Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

13.5.1. Cardiovascular

13.5.2. Oncology and Hematology

13.5.3. Infectious Diseases

13.5.4. Neurology

13.5.5. Rare Diseases

13.5.6. Respiratory

13.5.7. Urology

13.5.8. Cell and Gene Therapy

13.5.9. Women’s Health

13.5.10. Vaccine Development

13.5.11. Others

13.6. North America Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

13.6.1. Pharmaceutical Companies

13.6.2. Biotechnology Companies

13.6.3. Medical Device Companies

13.6.4. Others

13.7. North America Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Country

13.7.1. U.S

13.7.1.1. U.S Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

13.7.1.1.1. Clinical Monitoring and Trial Management

13.7.1.1.2. Data and Project Management

13.7.1.1.3. Medical Writing and Publishing

13.7.1.1.4. Regulatory Services

13.7.1.1.5. Patient Recruitment and Retention

13.7.1.1.6. Safety and Pharmacovigilance

13.7.1.1.7. Statistical Review and Reporting

13.7.1.1.8. Consulting Services

13.7.1.1.9. Others

13.7.1.2. U.S Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

13.7.1.2.1. Planning and Discovery

13.7.1.2.2. Phase I

13.7.1.2.3. Phase II

13.7.1.2.4. Phase III

13.7.1.2.5. Phase IV

13.7.1.2.6. Post Launch

13.7.1.3. U.S Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

13.7.1.3.1. Small and Medium Organizations

13.7.1.3.2. Large Organizations

13.7.1.4. U.S Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

13.7.1.4.1. Cardiovascular

13.7.1.4.2. Oncology and Hematology

13.7.1.4.3. Infectious Diseases

13.7.1.4.4. Neurology

13.7.1.4.5. Rare Diseases

13.7.1.4.6. Respiratory

13.7.1.4.7. Urology

13.7.1.4.8. Cell and Gene Therapy

13.7.1.4.9. Women’s Health

13.7.1.4.10. Vaccine Development

13.7.1.4.11. Others

13.7.1.5. U.S Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

13.7.1.5.1. Pharmaceutical Companies

13.7.1.5.2. Biotechnology Companies

13.7.1.5.3. Medical Device Companies

13.7.1.5.4. Others

13.7.2. Canada

13.7.2.1. Canada Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

13.7.2.1.1. Clinical Monitoring and Trial Management

13.7.2.1.2. Data and Project Management

13.7.2.1.3. Medical Writing and Publishing

13.7.2.1.4. Regulatory Services

13.7.2.1.5. Patient Recruitment and Retention

13.7.2.1.6. Safety and Pharmacovigilance

13.7.2.1.7. Statistical Review and Reporting

13.7.2.1.8. Consulting Services

13.7.2.1.9. Others

13.7.2.2. Canada Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

13.7.2.2.1. Planning and Discovery

13.7.2.2.2. Phase I

13.7.2.2.3. Phase II

13.7.2.2.4. Phase III

13.7.2.2.5. Phase IV

13.7.2.2.6. Post Launch

13.7.2.3. Canada Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

13.7.2.3.1. Small and Medium Organizations

13.7.2.3.2. Large Organizations

13.7.2.4. Canada Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

13.7.2.4.1. Cardiovascular

13.7.2.4.2. Oncology and Hematology

13.7.2.4.3. Infectious Diseases

13.7.2.4.4. Neurology

13.7.2.4.5. Rare Diseases

13.7.2.4.6. Respiratory

13.7.2.4.7. Urology

13.7.2.4.8. Cell and Gene Therapy

13.7.2.4.9. Women’s Health

13.7.2.4.10. Vaccine Development

13.7.2.4.11. Others

13.7.2.5. Canada Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

13.7.2.5.1. Pharmaceutical Companies

13.7.2.5.2. Biotechnology Companies

13.7.2.5.3. Medical Device Companies

13.7.2.5.4. Others

13.7.3. Mexico

13.7.3.1. Mexico Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

13.7.3.1.1. Clinical Monitoring and Trial Management

13.7.3.1.2. Data and Project Management

13.7.3.1.3. Medical Writing and Publishing

13.7.3.1.4. Regulatory Services

13.7.3.1.5. Patient Recruitment and Retention

13.7.3.1.6. Safety and Pharmacovigilance

13.7.3.1.7. Statistical Review and Reporting

13.7.3.1.8. Consulting Services

13.7.3.1.9. Others

13.7.3.2. Mexico Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

13.7.3.2.1. Planning and Discovery

13.7.3.2.2. Phase I

13.7.3.2.3. Phase II

13.7.3.2.4. Phase III

13.7.3.2.5. Phase IV

13.7.3.2.6. Post Launch

13.7.3.3. Mexico Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

13.7.3.3.1. Small and Medium Organizations

13.7.3.3.2. Large Organizations

13.7.3.4. Mexico Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

13.7.3.4.1. Cardiovascular

13.7.3.4.2. Oncology and Hematology

13.7.3.4.3. Infectious Diseases

13.7.3.4.4. Neurology

13.7.3.4.5. Rare Diseases

13.7.3.4.6. Respiratory

13.7.3.4.7. Urology

13.7.3.4.8. Cell and Gene Therapy

13.7.3.4.9. Women’s Health

13.7.3.4.10. Vaccine Development

13.7.3.4.11. Others

13.7.3.5. Mexico Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

13.7.3.5.1. Pharmaceutical Companies

13.7.3.5.2. Biotechnology Companies

13.7.3.5.3. Medical Device Companies

13.7.3.5.4. Others

13.7.4. Rest of North America

13.7.4.1. Rest of North America Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

13.7.4.1.1. Clinical Monitoring and Trial Management

13.7.4.1.2. Data and Project Management

13.7.4.1.3. Medical Writing and Publishing

13.7.4.1.4. Regulatory Services

13.7.4.1.5. Patient Recruitment and Retention

13.7.4.1.6. Safety and Pharmacovigilance

13.7.4.1.7. Statistical Review and Reporting

13.7.4.1.8. Consulting Services

13.7.4.1.9. Others

13.7.4.2. Rest of North America Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

13.7.4.2.1. Planning and Discovery

13.7.4.2.2. Phase I

13.7.4.2.3. Phase II

13.7.4.2.4. Phase III

13.7.4.2.5. Phase IV

13.7.4.2.6. Post Launch

13.7.4.3. Rest of North America Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

13.7.4.3.1. Small and Medium Organizations

13.7.4.3.2. Large Organizations

13.7.4.4. Rest of North America Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

13.7.4.4.1. Cardiovascular

13.7.4.4.2. Oncology and Hematology

13.7.4.4.3. Infectious Diseases

13.7.4.4.4. Neurology

13.7.4.4.5. Rare Diseases

13.7.4.4.6. Respiratory

13.7.4.4.7. Urology

13.7.4.4.8. Cell and Gene Therapy

13.7.4.4.9. Women’s Health

13.7.4.4.10. Vaccine Development

13.7.4.4.11. Others

13.7.4.5. Rest of North America Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

13.7.4.5.1. Pharmaceutical Companies

13.7.4.5.2. Biotechnology Companies

13.7.4.5.3. Medical Device Companies

13.7.4.5.4. Others

13.8. Key Segment for Channeling Investments

13.8.1. By Country

13.8.2. By Services

13.8.3. By Development Phase

13.8.4. By Organization Size

13.8.5. By Therapeutic Areas

13.8.6. By End Users

14. Europe Healthcare Contract Research Organizations Market Analysis and Forecasts, 2021 - 2029

14.1. Overview

14.1.1. Europe Healthcare Contract Research Organizations Market Revenue (US$ Mn)

14.2. Europe Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

14.2.1. Clinical Monitoring and Trial Management

14.2.2. Data and Project Management

14.2.3. Medical Writing and Publishing

14.2.4. Regulatory Services

14.2.5. Patient Recruitment and Retention

14.2.6. Safety and Pharmacovigilance

14.2.7. Statistical Review and Reporting

14.2.8. Consulting Services

14.2.9. Others

14.3. Europe Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

14.3.1. Planning and Discovery

14.3.2. Phase I

14.3.3. Phase II

14.3.4. Phase III

14.3.5. Phase IV

14.3.6. Post Launch

14.4. Europe Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

14.4.1. Small and Medium Organizations

14.4.2. Large Organizations

14.5. Europe Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

14.5.1. Cardiovascular

14.5.2. Oncology and Hematology

14.5.3. Infectious Diseases

14.5.4. Neurology

14.5.5. Rare Diseases

14.5.6. Respiratory

14.5.7. Urology

14.5.8. Cell and Gene Therapy

14.5.9. Women’s Health

14.5.10. Vaccine Development

14.5.11. Others

14.6. Europe Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

14.6.1. Pharmaceutical Companies

14.6.2. Biotechnology Companies

14.6.3. Medical Device Companies

14.6.4. Others

14.7. Europe Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Country

14.7.1. France

14.7.1.1. France Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

14.7.1.1.1. Clinical Monitoring and Trial Management

14.7.1.1.2. Data and Project Management

14.7.1.1.3. Medical Writing and Publishing

14.7.1.1.4. Regulatory Services

14.7.1.1.5. Patient Recruitment and Retention

14.7.1.1.6. Safety and Pharmacovigilance

14.7.1.1.7. Statistical Review and Reporting

14.7.1.1.8. Consulting Services

14.7.1.1.9. Others

14.7.1.2. France Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

14.7.1.2.1. Planning and Discovery

14.7.1.2.2. Phase I

14.7.1.2.3. Phase II

14.7.1.2.4. Phase III

14.7.1.2.5. Phase IV

14.7.1.2.6. Post Launch

14.7.1.3. France Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

14.7.1.3.1. Small and Medium Organizations

14.7.1.3.2. Large Organizations

14.7.1.4. France Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

14.7.1.4.1. Cardiovascular

14.7.1.4.2. Oncology and Hematology

14.7.1.4.3. Infectious Diseases

14.7.1.4.4. Neurology

14.7.1.4.5. Rare Diseases

14.7.1.4.6. Respiratory

14.7.1.4.7. Urology

14.7.1.4.8. Cell and Gene Therapy

14.7.1.4.9. Women’s Health

14.7.1.4.10. Vaccine Development

14.7.1.4.11. Others

14.7.1.5. France Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

14.7.1.5.1. Pharmaceutical Companies

14.7.1.5.2. Biotechnology Companies

14.7.1.5.3. Medical Device Companies

14.7.1.5.4. Others

14.7.2. The UK

14.7.2.1. The UK Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

14.7.2.1.1. Clinical Monitoring and Trial Management

14.7.2.1.2. Data and Project Management

14.7.2.1.3. Medical Writing and Publishing

14.7.2.1.4. Regulatory Services

14.7.2.1.5. Patient Recruitment and Retention

14.7.2.1.6. Safety and Pharmacovigilance

14.7.2.1.7. Statistical Review and Reporting

14.7.2.1.8. Consulting Services

14.7.2.1.9. Others

14.7.2.2. The UK Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

14.7.2.2.1. Planning and Discovery

14.7.2.2.2. Phase I

14.7.2.2.3. Phase II

14.7.2.2.4. Phase III

14.7.2.2.5. Phase IV

14.7.2.2.6. Post Launch

14.7.2.3. The UK Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

14.7.2.3.1. Small and Medium Organizations

14.7.2.3.2. Large Organizations

14.7.2.4. The UK Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

14.7.2.4.1. Cardiovascular

14.7.2.4.2. Oncology and Hematology

14.7.2.4.3. Infectious Diseases

14.7.2.4.4. Neurology

14.7.2.4.5. Rare Diseases

14.7.2.4.6. Respiratory

14.7.2.4.7. Urology

14.7.2.4.8. Cell and Gene Therapy

14.7.2.4.9. Women’s Health

14.7.2.4.10. Vaccine Development

14.7.2.4.11. Others

14.7.2.5. The UK Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

14.7.2.5.1. Pharmaceutical Companies

14.7.2.5.2. Biotechnology Companies

14.7.2.5.3. Medical Device Companies

14.7.2.5.4. Others

14.7.3. Spain

14.7.3.1. Spain Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

14.7.3.1.1. Clinical Monitoring and Trial Management

14.7.3.1.2. Data and Project Management

14.7.3.1.3. Medical Writing and Publishing

14.7.3.1.4. Regulatory Services

14.7.3.1.5. Patient Recruitment and Retention

14.7.3.1.6. Safety and Pharmacovigilance

14.7.3.1.7. Statistical Review and Reporting

14.7.3.1.8. Consulting Services

14.7.3.1.9. Others

14.7.3.2. Spain Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

14.7.3.2.1. Planning and Discovery

14.7.3.2.2. Phase I

14.7.3.2.3. Phase II

14.7.3.2.4. Phase III

14.7.3.2.5. Phase IV

14.7.3.2.6. Post Launch

14.7.3.3. Spain Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

14.7.3.3.1. Small and Medium Organizations

14.7.3.3.2. Large Organizations

14.7.3.4. Spain Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

14.7.3.4.1. Cardiovascular

14.7.3.4.2. Oncology and Hematology

14.7.3.4.3. Infectious Diseases

14.7.3.4.4. Neurology

14.7.3.4.5. Rare Diseases

14.7.3.4.6. Respiratory

14.7.3.4.7. Urology

14.7.3.4.8. Cell and Gene Therapy

14.7.3.4.9. Women’s Health

14.7.3.4.10. Vaccine Development

14.7.3.4.11. Others

14.7.3.5. Spain Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

14.7.3.5.1. Pharmaceutical Companies

14.7.3.5.2. Biotechnology Companies

14.7.3.5.3. Medical Device Companies

14.7.3.5.4. Others

14.7.4. Germany

14.7.4.1. Germany Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

14.7.4.1.1. Clinical Monitoring and Trial Management

14.7.4.1.2. Data and Project Management

14.7.4.1.3. Medical Writing and Publishing

14.7.4.1.4. Regulatory Services

14.7.4.1.5. Patient Recruitment and Retention

14.7.4.1.6. Safety and Pharmacovigilance

14.7.4.1.7. Statistical Review and Reporting

14.7.4.1.8. Consulting Services

14.7.4.1.9. Others

14.7.4.2. Germany Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

14.7.4.2.1. Planning and Discovery

14.7.4.2.2. Phase I

14.7.4.2.3. Phase II

14.7.4.2.4. Phase III

14.7.4.2.5. Phase IV

14.7.4.2.6. Post Launch

14.7.4.3. Germany Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

14.7.4.3.1. Small and Medium Organizations

14.7.4.3.2. Large Organizations

14.7.4.4. Germany Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

14.7.4.4.1. Cardiovascular

14.7.4.4.2. Oncology and Hematology

14.7.4.4.3. Infectious Diseases

14.7.4.4.4. Neurology

14.7.4.4.5. Rare Diseases

14.7.4.4.6. Respiratory

14.7.4.4.7. Urology

14.7.4.4.8. Cell and Gene Therapy

14.7.4.4.9. Women’s Health

14.7.4.4.10. Vaccine Development

14.7.4.4.11. Others

14.7.4.5. Germany Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

14.7.4.5.1. Pharmaceutical Companies

14.7.4.5.2. Biotechnology Companies

14.7.4.5.3. Medical Device Companies

14.7.4.5.4. Others

14.7.5. Italy

14.7.5.1. Italy Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

14.7.5.1.1. Clinical Monitoring and Trial Management

14.7.5.1.2. Data and Project Management

14.7.5.1.3. Medical Writing and Publishing

14.7.5.1.4. Regulatory Services

14.7.5.1.5. Patient Recruitment and Retention

14.7.5.1.6. Safety and Pharmacovigilance

14.7.5.1.7. Statistical Review and Reporting

14.7.5.1.8. Consulting Services

14.7.5.1.9. Others

14.7.5.2. Italy Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

14.7.5.2.1. Planning and Discovery

14.7.5.2.2. Phase I

14.7.5.2.3. Phase II

14.7.5.2.4. Phase III

14.7.5.2.5. Phase IV

14.7.5.2.6. Post Launch

14.7.5.3. Italy Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

14.7.5.3.1. Small and Medium Organizations

14.7.5.3.2. Large Organizations

14.7.5.4. Italy Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

14.7.5.4.1. Cardiovascular

14.7.5.4.2. Oncology and Hematology

14.7.5.4.3. Infectious Diseases

14.7.5.4.4. Neurology

14.7.5.4.5. Rare Diseases

14.7.5.4.6. Respiratory

14.7.5.4.7. Urology

14.7.5.4.8. Cell and Gene Therapy

14.7.5.4.9. Women’s Health

14.7.5.4.10. Vaccine Development

14.7.5.4.11. Others

14.7.5.5. Italy Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

14.7.5.5.1. Pharmaceutical Companies

14.7.5.5.2. Biotechnology Companies

14.7.5.5.3. Medical Device Companies

14.7.5.5.4. Others

14.7.6. Nordic Countries

14.7.6.1. Nordic Countries Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

14.7.6.1.1. Clinical Monitoring and Trial Management

14.7.6.1.2. Data and Project Management

14.7.6.1.3. Medical Writing and Publishing

14.7.6.1.4. Regulatory Services

14.7.6.1.5. Patient Recruitment and Retention

14.7.6.1.6. Safety and Pharmacovigilance

14.7.6.1.7. Statistical Review and Reporting

14.7.6.1.8. Consulting Services

14.7.6.1.9. Others

14.7.6.2. Nordic Countries Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

14.7.6.2.1. Planning and Discovery

14.7.6.2.2. Phase I

14.7.6.2.3. Phase II

14.7.6.2.4. Phase III

14.7.6.2.5. Phase IV

14.7.6.2.6. Post Launch

14.7.6.3. Nordic Countries Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

14.7.6.3.1. Small and Medium Organizations

14.7.6.3.2. Large Organizations

14.7.6.4. Nordic Countries Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

14.7.6.4.1. Cardiovascular

14.7.6.4.2. Oncology and Hematology

14.7.6.4.3. Infectious Diseases

14.7.6.4.4. Neurology

14.7.6.4.5. Rare Diseases

14.7.6.4.6. Respiratory

14.7.6.4.7. Urology

14.7.6.4.8. Cell and Gene Therapy

14.7.6.4.9. Women’s Health

14.7.6.4.10. Vaccine Development

14.7.6.4.11. Others

14.7.6.5. Nordic Countries Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

14.7.6.5.1. Pharmaceutical Companies

14.7.6.5.2. Biotechnology Companies

14.7.6.5.3. Medical Device Companies

14.7.6.5.4. Others

14.7.6.6. Nordic Countries Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Country

14.7.6.6.1. Denmark

14.7.6.6.2. Finland

14.7.6.6.3. Iceland

14.7.6.6.4. Sweden

14.7.6.6.5. Norway

14.7.7. Benelux Union

14.7.7.1. Benelux Union Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

14.7.7.1.1. Clinical Monitoring and Trial Management

14.7.7.1.2. Data and Project Management

14.7.7.1.3. Medical Writing and Publishing

14.7.7.1.4. Regulatory Services

14.7.7.1.5. Patient Recruitment and Retention

14.7.7.1.6. Safety and Pharmacovigilance

14.7.7.1.7. Statistical Review and Reporting

14.7.7.1.8. Consulting Services

14.7.7.1.9. Others

14.7.7.2. Benelux Union Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

14.7.7.2.1. Planning and Discovery

14.7.7.2.2. Phase I

14.7.7.2.3. Phase II

14.7.7.2.4. Phase III

14.7.7.2.5. Phase IV

14.7.7.2.6. Post Launch

14.7.7.3. Benelux Union Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

14.7.7.3.1. Small and Medium Organizations

14.7.7.3.2. Large Organizations

14.7.7.4. Benelux Union Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

14.7.7.4.1. Cardiovascular

14.7.7.4.2. Oncology and Hematology

14.7.7.4.3. Infectious Diseases

14.7.7.4.4. Neurology

14.7.7.4.5. Rare Diseases

14.7.7.4.6. Respiratory

14.7.7.4.7. Urology

14.7.7.4.8. Cell and Gene Therapy

14.7.7.4.9. Women’s Health

14.7.7.4.10. Vaccine Development

14.7.7.4.11. Others

14.7.7.5. Benelux Union Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

14.7.7.5.1. Pharmaceutical Companies

14.7.7.5.2. Biotechnology Companies

14.7.7.5.3. Medical Device Companies

14.7.7.5.4. Others

14.7.7.6. Benelux Union Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Country

14.7.7.6.1. Belgium

14.7.7.6.2. The Netherlands

14.7.7.6.3. Luxembourg

14.7.8. Rest of Europe

14.7.8.1. Rest of Europe Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

14.7.8.1.1. Clinical Monitoring and Trial Management

14.7.8.1.2. Data and Project Management

14.7.8.1.3. Medical Writing and Publishing

14.7.8.1.4. Regulatory Services

14.7.8.1.5. Patient Recruitment and Retention

14.7.8.1.6. Safety and Pharmacovigilance

14.7.8.1.7. Statistical Review and Reporting

14.7.8.1.8. Consulting Services

14.7.8.1.9. Others

14.7.8.2. Rest of Europe Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

14.7.8.2.1. Planning and Discovery

14.7.8.2.2. Phase I

14.7.8.2.3. Phase II

14.7.8.2.4. Phase III

14.7.8.2.5. Phase IV

14.7.8.2.6. Post Launch

14.7.8.3. Rest of Europe Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

14.7.8.3.1. Small and Medium Organizations

14.7.8.3.2. Large Organizations

14.7.8.4. Rest of Europe Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

14.7.8.4.1. Cardiovascular

14.7.8.4.2. Oncology and Hematology

14.7.8.4.3. Infectious Diseases

14.7.8.4.4. Neurology

14.7.8.4.5. Rare Diseases

14.7.8.4.6. Respiratory

14.7.8.4.7. Urology

14.7.8.4.8. Cell and Gene Therapy

14.7.8.4.9. Women’s Health

14.7.8.4.10. Vaccine Development

14.7.8.4.11. Others

14.7.8.5. Rest of Europe Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

14.7.8.5.1. Pharmaceutical Companies

14.7.8.5.2. Biotechnology Companies

14.7.8.5.3. Medical Device Companies

14.7.8.5.4. Others

14.8. Key Segment for Channeling Investments

14.8.1. By Country

14.8.2. By Services

14.8.3. By Development Phase

14.8.4. By Organization Size

14.8.5. By Therapeutic Areas

14.8.6. By End Users

15. Asia Pacific Healthcare Contract Research Organizations Market Analysis and Forecasts, 2021 - 2029

15.1. Overview

15.1.1. Asia Pacific Healthcare Contract Research Organizations Market Revenue (US$ Mn)

15.2. Asia Pacific Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

15.2.1. Clinical Monitoring and Trial Management

15.2.2. Data and Project Management

15.2.3. Medical Writing and Publishing

15.2.4. Regulatory Services

15.2.5. Patient Recruitment and Retention

15.2.6. Safety and Pharmacovigilance

15.2.7. Statistical Review and Reporting

15.2.8. Consulting Services

15.2.9. Others

15.3. Asia Pacific Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

15.3.1. Planning and Discovery

15.3.2. Phase I

15.3.3. Phase II

15.3.4. Phase III

15.3.5. Phase IV

15.3.6. Post Launch

15.4. Asia Pacific Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

15.4.1. Small and Medium Organizations

15.4.2. Large Organizations

15.5. Asia Pacific Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

15.5.1. Cardiovascular

15.5.2. Oncology and Hematology

15.5.3. Infectious Diseases

15.5.4. Neurology

15.5.5. Rare Diseases

15.5.6. Respiratory

15.5.7. Urology

15.5.8. Cell and Gene Therapy

15.5.9. Women’s Health

15.5.10. Vaccine Development

15.5.11. Others

15.6. Asia Pacific Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

15.6.1. Pharmaceutical Companies

15.6.2. Biotechnology Companies

15.6.3. Medical Device Companies

15.6.4. Others

15.7. Asia Pacific Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Country

15.7.1. China

15.7.1.1. China Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

15.7.1.1.1. Clinical Monitoring and Trial Management

15.7.1.1.2. Data and Project Management

15.7.1.1.3. Medical Writing and Publishing

15.7.1.1.4. Regulatory Services

15.7.1.1.5. Patient Recruitment and Retention

15.7.1.1.6. Safety and Pharmacovigilance

15.7.1.1.7. Statistical Review and Reporting

15.7.1.1.8. Consulting Services

15.7.1.1.9. Others

15.7.1.2. China Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

15.7.1.2.1. Planning and Discovery

15.7.1.2.2. Phase I

15.7.1.2.3. Phase II

15.7.1.2.4. Phase III

15.7.1.2.5. Phase IV

15.7.1.2.6. Post Launch

15.7.1.3. China Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

15.7.1.3.1. Small and Medium Organizations

15.7.1.3.2. Large Organizations

15.7.1.4. China Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

15.7.1.4.1. Cardiovascular

15.7.1.4.2. Oncology and Hematology

15.7.1.4.3. Infectious Diseases

15.7.1.4.4. Neurology

15.7.1.4.5. Rare Diseases

15.7.1.4.6. Respiratory

15.7.1.4.7. Urology

15.7.1.4.8. Cell and Gene Therapy

15.7.1.4.9. Women’s Health

15.7.1.4.10. Vaccine Development

15.7.1.4.11. Others

15.7.1.5. China Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

15.7.1.5.1. Pharmaceutical Companies

15.7.1.5.2. Biotechnology Companies

15.7.1.5.3. Medical Device Companies

15.7.1.5.4. Others

15.7.2. Japan

15.7.2.1. Japan Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

15.7.2.1.1. Clinical Monitoring and Trial Management

15.7.2.1.2. Data and Project Management

15.7.2.1.3. Medical Writing and Publishing

15.7.2.1.4. Regulatory Services

15.7.2.1.5. Patient Recruitment and Retention

15.7.2.1.6. Safety and Pharmacovigilance

15.7.2.1.7. Statistical Review and Reporting

15.7.2.1.8. Consulting Services

15.7.2.1.9. Others

15.7.2.2. Japan Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

15.7.2.2.1. Planning and Discovery

15.7.2.2.2. Phase I

15.7.2.2.3. Phase II

15.7.2.2.4. Phase III

15.7.2.2.5. Phase IV

15.7.2.2.6. Post Launch

15.7.2.3. Japan Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

15.7.2.3.1. Small and Medium Organizations

15.7.2.3.2. Large Organizations

15.7.2.4. Japan Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

15.7.2.4.1. Cardiovascular

15.7.2.4.2. Oncology and Hematology

15.7.2.4.3. Infectious Diseases

15.7.2.4.4. Neurology

15.7.2.4.5. Rare Diseases

15.7.2.4.6. Respiratory

15.7.2.4.7. Urology

15.7.2.4.8. Cell and Gene Therapy

15.7.2.4.9. Women’s Health

15.7.2.4.10. Vaccine Development

15.7.2.4.11. Others

15.7.2.5. Japan Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

15.7.2.5.1. Pharmaceutical Companies

15.7.2.5.2. Biotechnology Companies

15.7.2.5.3. Medical Device Companies

15.7.2.5.4. Others

15.7.3. India

15.7.3.1. India Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

15.7.3.1.1. Clinical Monitoring and Trial Management

15.7.3.1.2. Data and Project Management

15.7.3.1.3. Medical Writing and Publishing

15.7.3.1.4. Regulatory Services

15.7.3.1.5. Patient Recruitment and Retention

15.7.3.1.6. Safety and Pharmacovigilance

15.7.3.1.7. Statistical Review and Reporting

15.7.3.1.8. Consulting Services

15.7.3.1.9. Others

15.7.3.2. India Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

15.7.3.2.1. Planning and Discovery

15.7.3.2.2. Phase I

15.7.3.2.3. Phase II

15.7.3.2.4. Phase III

15.7.3.2.5. Phase IV

15.7.3.2.6. Post Launch

15.7.3.3. India Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

15.7.3.3.1. Small and Medium Organizations

15.7.3.3.2. Large Organizations

15.7.3.4. India Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

15.7.3.4.1. Cardiovascular

15.7.3.4.2. Oncology and Hematology

15.7.3.4.3. Infectious Diseases

15.7.3.4.4. Neurology

15.7.3.4.5. Rare Diseases

15.7.3.4.6. Respiratory

15.7.3.4.7. Urology

15.7.3.4.8. Cell and Gene Therapy

15.7.3.4.9. Women’s Health

15.7.3.4.10. Vaccine Development

15.7.3.4.11. Others

15.7.3.5. India Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

15.7.3.5.1. Pharmaceutical Companies

15.7.3.5.2. Biotechnology Companies

15.7.3.5.3. Medical Device Companies

15.7.3.5.4. Others

15.7.4. New Zealand

15.7.4.1. New Zealand Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

15.7.4.1.1. Clinical Monitoring and Trial Management

15.7.4.1.2. Data and Project Management

15.7.4.1.3. Medical Writing and Publishing

15.7.4.1.4. Regulatory Services

15.7.4.1.5. Patient Recruitment and Retention

15.7.4.1.6. Safety and Pharmacovigilance

15.7.4.1.7. Statistical Review and Reporting

15.7.4.1.8. Consulting Services

15.7.4.1.9. Others

15.7.4.2. New Zealand Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

15.7.4.2.1. Planning and Discovery

15.7.4.2.2. Phase I

15.7.4.2.3. Phase II

15.7.4.2.4. Phase III

15.7.4.2.5. Phase IV

15.7.4.2.6. Post Launch

15.7.4.3. New Zealand Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

15.7.4.3.1. Small and Medium Organizations

15.7.4.3.2. Large Organizations

15.7.4.4. New Zealand Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

15.7.4.4.1. Cardiovascular

15.7.4.4.2. Oncology and Hematology

15.7.4.4.3. Infectious Diseases

15.7.4.4.4. Neurology

15.7.4.4.5. Rare Diseases

15.7.4.4.6. Respiratory

15.7.4.4.7. Urology

15.7.4.4.8. Cell and Gene Therapy

15.7.4.4.9. Women’s Health

15.7.4.4.10. Vaccine Development

15.7.4.4.11. Others

15.7.4.5. New Zealand Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

15.7.4.5.1. Pharmaceutical Companies

15.7.4.5.2. Biotechnology Companies

15.7.4.5.3. Medical Device Companies

15.7.4.5.4. Others

15.7.5. Australia

15.7.5.1. Australia Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

15.7.5.1.1. Clinical Monitoring and Trial Management

15.7.5.1.2. Data and Project Management

15.7.5.1.3. Medical Writing and Publishing

15.7.5.1.4. Regulatory Services

15.7.5.1.5. Patient Recruitment and Retention

15.7.5.1.6. Safety and Pharmacovigilance

15.7.5.1.7. Statistical Review and Reporting

15.7.5.1.8. Consulting Services

15.7.5.1.9. Others

15.7.5.2. Australia Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

15.7.5.2.1. Planning and Discovery

15.7.5.2.2. Phase I

15.7.5.2.3. Phase II

15.7.5.2.4. Phase III

15.7.5.2.5. Phase IV

15.7.5.2.6. Post Launch

15.7.5.3. Australia Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

15.7.5.3.1. Small and Medium Organizations

15.7.5.3.2. Large Organizations

15.7.5.4. Australia Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

15.7.5.4.1. Cardiovascular

15.7.5.4.2. Oncology and Hematology

15.7.5.4.3. Infectious Diseases

15.7.5.4.4. Neurology

15.7.5.4.5. Rare Diseases

15.7.5.4.6. Respiratory

15.7.5.4.7. Urology

15.7.5.4.8. Cell and Gene Therapy

15.7.5.4.9. Women’s Health

15.7.5.4.10. Vaccine Development

15.7.5.4.11. Others

15.7.5.5. Australia Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

15.7.5.5.1. Pharmaceutical Companies

15.7.5.5.2. Biotechnology Companies

15.7.5.5.3. Medical Device Companies

15.7.5.5.4. Others

15.7.6. South Korea

15.7.6.1. South Korea Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

15.7.6.1.1. Clinical Monitoring and Trial Management

15.7.6.1.2. Data and Project Management

15.7.6.1.3. Medical Writing and Publishing

15.7.6.1.4. Regulatory Services

15.7.6.1.5. Patient Recruitment and Retention

15.7.6.1.6. Safety and Pharmacovigilance

15.7.6.1.7. Statistical Review and Reporting

15.7.6.1.8. Consulting Services

15.7.6.1.9. Others

15.7.6.2. South Korea Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

15.7.6.2.1. Planning and Discovery

15.7.6.2.2. Phase I

15.7.6.2.3. Phase II

15.7.6.2.4. Phase III

15.7.6.2.5. Phase IV

15.7.6.2.6. Post Launch

15.7.6.3. South Korea Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

15.7.6.3.1. Small and Medium Organizations

15.7.6.3.2. Large Organizations

15.7.6.4. South Korea Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

15.7.6.4.1. Cardiovascular

15.7.6.4.2. Oncology and Hematology

15.7.6.4.3. Infectious Diseases

15.7.6.4.4. Neurology

15.7.6.4.5. Rare Diseases

15.7.6.4.6. Respiratory

15.7.6.4.7. Urology

15.7.6.4.8. Cell and Gene Therapy

15.7.6.4.9. Women’s Health

15.7.6.4.10. Vaccine Development

15.7.6.4.11. Others

15.7.6.5. South Korea Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

15.7.6.5.1. Pharmaceutical Companies

15.7.6.5.2. Biotechnology Companies

15.7.6.5.3. Medical Device Companies

15.7.6.5.4. Others

15.7.7. Southeast Asia

15.7.7.1. Southeast Asia Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

15.7.7.1.1. Clinical Monitoring and Trial Management

15.7.7.1.2. Data and Project Management

15.7.7.1.3. Medical Writing and Publishing

15.7.7.1.4. Regulatory Services

15.7.7.1.5. Patient Recruitment and Retention

15.7.7.1.6. Safety and Pharmacovigilance

15.7.7.1.7. Statistical Review and Reporting

15.7.7.1.8. Consulting Services

15.7.7.1.9. Others

15.7.7.2. Southeast Asia Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

15.7.7.2.1. Planning and Discovery

15.7.7.2.2. Phase I

15.7.7.2.3. Phase II

15.7.7.2.4. Phase III

15.7.7.2.5. Phase IV

15.7.7.2.6. Post Launch

15.7.7.3. Southeast Asia Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

15.7.7.3.1. Small and Medium Organizations

15.7.7.3.2. Large Organizations

15.7.7.4. Southeast Asia Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

15.7.7.4.1. Cardiovascular

15.7.7.4.2. Oncology and Hematology

15.7.7.4.3. Infectious Diseases

15.7.7.4.4. Neurology

15.7.7.4.5. Rare Diseases

15.7.7.4.6. Respiratory

15.7.7.4.7. Urology

15.7.7.4.8. Cell and Gene Therapy

15.7.7.4.9. Women’s Health

15.7.7.4.10. Vaccine Development

15.7.7.4.11. Others

15.7.7.5. Southeast Asia Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

15.7.7.5.1. Pharmaceutical Companies

15.7.7.5.2. Biotechnology Companies

15.7.7.5.3. Medical Device Companies

15.7.7.5.4. Others

15.7.7.6. Southeast Asia Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Country

15.7.7.6.1. Indonesia

15.7.7.6.2. Thailand

15.7.7.6.3. Malaysia

15.7.7.6.4. Singapore

15.7.7.6.5. Rest of Southeast Asia

15.7.8. Rest of Asia Pacific

15.7.8.1. Rest of Asia Pacific Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

15.7.8.1.1. Clinical Monitoring and Trial Management

15.7.8.1.2. Data and Project Management

15.7.8.1.3. Medical Writing and Publishing

15.7.8.1.4. Regulatory Services

15.7.8.1.5. Patient Recruitment and Retention

15.7.8.1.6. Safety and Pharmacovigilance

15.7.8.1.7. Statistical Review and Reporting

15.7.8.1.8. Consulting Services

15.7.8.1.9. Others

15.7.8.2. Rest of Asia Pacific Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

15.7.8.2.1. Planning and Discovery

15.7.8.2.2. Phase I

15.7.8.2.3. Phase II

15.7.8.2.4. Phase III

15.7.8.2.5. Phase IV

15.7.8.2.6. Post Launch

15.7.8.3. Rest of Asia Pacific Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

15.7.8.3.1. Small and Medium Organizations

15.7.8.3.2. Large Organizations

15.7.8.4. Rest of Asia Pacific Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

15.7.8.4.1. Cardiovascular

15.7.8.4.2. Oncology and Hematology

15.7.8.4.3. Infectious Diseases

15.7.8.4.4. Neurology

15.7.8.4.5. Rare Diseases

15.7.8.4.6. Respiratory

15.7.8.4.7. Urology

15.7.8.4.8. Cell and Gene Therapy

15.7.8.4.9. Women’s Health

15.7.8.4.10. Vaccine Development

15.7.8.4.11. Others

15.7.8.5. Rest of Asia Pacific Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

15.7.8.5.1. Pharmaceutical Companies

15.7.8.5.2. Biotechnology Companies

15.7.8.5.3. Medical Device Companies

15.7.8.5.4. Others

15.8. Key Segment for Channeling Investments

15.8.1. By Country

15.8.2. By Services

15.8.3. By Development Phase

15.8.4. By Organization Size

15.8.5. By Therapeutic Areas

15.8.6. By End Users

16. Middle East and Africa Healthcare Contract Research Organizations Market Analysis and Forecasts, 2021 - 2029

16.1. Overview

16.1.1. Middle East and Africa Healthcare Contract Research Organizations Market Revenue (US$ Mn)

16.2. Middle East and Africa Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

16.2.1. Clinical Monitoring and Trial Management

16.2.2. Data and Project Management

16.2.3. Medical Writing and Publishing

16.2.4. Regulatory Services

16.2.5. Patient Recruitment and Retention

16.2.6. Safety and Pharmacovigilance

16.2.7. Statistical Review and Reporting

16.2.8. Consulting Services

16.2.9. Others

16.3. Middle East and Africa Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

16.3.1. Planning and Discovery

16.3.2. Phase I

16.3.3. Phase II

16.3.4. Phase III

16.3.5. Phase IV

16.3.6. Post Launch

16.4. Middle East and Africa Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

16.4.1. Small and Medium Organizations

16.4.2. Large Organizations

16.5. Middle East and Africa Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

16.5.1. Cardiovascular

16.5.2. Oncology and Hematology

16.5.3. Infectious Diseases

16.5.4. Neurology

16.5.5. Rare Diseases

16.5.6. Respiratory

16.5.7. Urology

16.5.8. Cell and Gene Therapy

16.5.9. Women’s Health

16.5.10. Vaccine Development

16.5.11. Others

16.6. Middle East and Africa Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

16.6.1. Pharmaceutical Companies

16.6.2. Biotechnology Companies

16.6.3. Medical Device Companies

16.6.4. Others

16.7. Middle East and Africa Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Country

16.7.1. Saudi Arabia

16.7.1.1. Saudi Arabia Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

16.7.1.1.1. Clinical Monitoring and Trial Management

16.7.1.1.2. Data and Project Management

16.7.1.1.3. Medical Writing and Publishing

16.7.1.1.4. Regulatory Services

16.7.1.1.5. Patient Recruitment and Retention

16.7.1.1.6. Safety and Pharmacovigilance

16.7.1.1.7. Statistical Review and Reporting

16.7.1.1.8. Consulting Services

16.7.1.1.9. Others

16.7.1.2. Saudi Arabia Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

16.7.1.2.1. Planning and Discovery

16.7.1.2.2. Phase I

16.7.1.2.3. Phase II

16.7.1.2.4. Phase III

16.7.1.2.5. Phase IV

16.7.1.2.6. Post Launch

16.7.1.3. Saudi Arabia Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

16.7.1.3.1. Small and Medium Organizations

16.7.1.3.2. Large Organizations

16.7.1.4. Saudi Arabia Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

16.7.1.4.1. Cardiovascular

16.7.1.4.2. Oncology and Hematology

16.7.1.4.3. Infectious Diseases

16.7.1.4.4. Neurology

16.7.1.4.5. Rare Diseases

16.7.1.4.6. Respiratory

16.7.1.4.7. Urology

16.7.1.4.8. Cell and Gene Therapy

16.7.1.4.9. Women’s Health

16.7.1.4.10. Vaccine Development

16.7.1.4.11. Others

16.7.1.5. Saudi Arabia Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

16.7.1.5.1. Pharmaceutical Companies

16.7.1.5.2. Biotechnology Companies

16.7.1.5.3. Medical Device Companies

16.7.1.5.4. Others

16.7.2. UAE

16.7.2.1. UAE Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

16.7.2.1.1. Clinical Monitoring and Trial Management

16.7.2.1.2. Data and Project Management

16.7.2.1.3. Medical Writing and Publishing

16.7.2.1.4. Regulatory Services

16.7.2.1.5. Patient Recruitment and Retention

16.7.2.1.6. Safety and Pharmacovigilance

16.7.2.1.7. Statistical Review and Reporting

16.7.2.1.8. Consulting Services

16.7.2.1.9. Others

16.7.2.2. UAE Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

16.7.2.2.1. Planning and Discovery

16.7.2.2.2. Phase I

16.7.2.2.3. Phase II

16.7.2.2.4. Phase III

16.7.2.2.5. Phase IV

16.7.2.2.6. Post Launch

16.7.2.3. UAE Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

16.7.2.3.1. Small and Medium Organizations

16.7.2.3.2. Large Organizations

16.7.2.4. UAE Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

16.7.2.4.1. Cardiovascular

16.7.2.4.2. Oncology and Hematology

16.7.2.4.3. Infectious Diseases

16.7.2.4.4. Neurology

16.7.2.4.5. Rare Diseases

16.7.2.4.6. Respiratory

16.7.2.4.7. Urology

16.7.2.4.8. Cell and Gene Therapy

16.7.2.4.9. Women’s Health

16.7.2.4.10. Vaccine Development

16.7.2.4.11. Others

16.7.2.5. UAE Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

16.7.2.5.1. Pharmaceutical Companies

16.7.2.5.2. Biotechnology Companies

16.7.2.5.3. Medical Device Companies

16.7.2.5.4. Others

16.7.3. Egypt

16.7.3.1. Egypt Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

16.7.3.1.1. Clinical Monitoring and Trial Management

16.7.3.1.2. Data and Project Management

16.7.3.1.3. Medical Writing and Publishing

16.7.3.1.4. Regulatory Services

16.7.3.1.5. Patient Recruitment and Retention

16.7.3.1.6. Safety and Pharmacovigilance

16.7.3.1.7. Statistical Review and Reporting

16.7.3.1.8. Consulting Services

16.7.3.1.9. Others

16.7.3.2. Egypt Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

16.7.3.2.1. Planning and Discovery

16.7.3.2.2. Phase I

16.7.3.2.3. Phase II

16.7.3.2.4. Phase III

16.7.3.2.5. Phase IV

16.7.3.2.6. Post Launch

16.7.3.3. Egypt Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

16.7.3.3.1. Small and Medium Organizations

16.7.3.3.2. Large Organizations

16.7.3.4. Egypt Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

16.7.3.4.1. Cardiovascular

16.7.3.4.2. Oncology and Hematology

16.7.3.4.3. Infectious Diseases

16.7.3.4.4. Neurology

16.7.3.4.5. Rare Diseases

16.7.3.4.6. Respiratory

16.7.3.4.7. Urology

16.7.3.4.8. Cell and Gene Therapy

16.7.3.4.9. Women’s Health

16.7.3.4.10. Vaccine Development

16.7.3.4.11. Others

16.7.3.5. Egypt Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

16.7.3.5.1. Pharmaceutical Companies

16.7.3.5.2. Biotechnology Companies

16.7.3.5.3. Medical Device Companies

16.7.3.5.4. Others

16.7.4. Kuwait

16.7.4.1. Kuwait Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

16.7.4.1.1. Clinical Monitoring and Trial Management

16.7.4.1.2. Data and Project Management

16.7.4.1.3. Medical Writing and Publishing

16.7.4.1.4. Regulatory Services

16.7.4.1.5. Patient Recruitment and Retention

16.7.4.1.6. Safety and Pharmacovigilance

16.7.4.1.7. Statistical Review and Reporting

16.7.4.1.8. Consulting Services

16.7.4.1.9. Others

16.7.4.2. Kuwait Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

16.7.4.2.1. Planning and Discovery

16.7.4.2.2. Phase I

16.7.4.2.3. Phase II

16.7.4.2.4. Phase III

16.7.4.2.5. Phase IV

16.7.4.2.6. Post Launch

16.7.4.3. Kuwait Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

16.7.4.3.1. Small and Medium Organizations

16.7.4.3.2. Large Organizations

16.7.4.4. Kuwait Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

16.7.4.4.1. Cardiovascular

16.7.4.4.2. Oncology and Hematology

16.7.4.4.3. Infectious Diseases

16.7.4.4.4. Neurology

16.7.4.4.5. Rare Diseases

16.7.4.4.6. Respiratory

16.7.4.4.7. Urology

16.7.4.4.8. Cell and Gene Therapy

16.7.4.4.9. Women’s Health

16.7.4.4.10. Vaccine Development

16.7.4.4.11. Others

16.7.4.5. Kuwait Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

16.7.4.5.1. Pharmaceutical Companies

16.7.4.5.2. Biotechnology Companies

16.7.4.5.3. Medical Device Companies

16.7.4.5.4. Others

16.7.5. South Africa

16.7.5.1. South Africa Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

16.7.5.1.1. Clinical Monitoring and Trial Management

16.7.5.1.2. Data and Project Management

16.7.5.1.3. Medical Writing and Publishing

16.7.5.1.4. Regulatory Services

16.7.5.1.5. Patient Recruitment and Retention

16.7.5.1.6. Safety and Pharmacovigilance

16.7.5.1.7. Statistical Review and Reporting

16.7.5.1.8. Consulting Services

16.7.5.1.9. Others

16.7.5.2. South Africa Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

16.7.5.2.1. Planning and Discovery

16.7.5.2.2. Phase I

16.7.5.2.3. Phase II

16.7.5.2.4. Phase III

16.7.5.2.5. Phase IV

16.7.5.2.6. Post Launch

16.7.5.3. South Africa Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

16.7.5.3.1. Small and Medium Organizations

16.7.5.3.2. Large Organizations

16.7.5.4. South Africa Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

16.7.5.4.1. Cardiovascular

16.7.5.4.2. Oncology and Hematology

16.7.5.4.3. Infectious Diseases

16.7.5.4.4. Neurology

16.7.5.4.5. Rare Diseases

16.7.5.4.6. Respiratory

16.7.5.4.7. Urology

16.7.5.4.8. Cell and Gene Therapy

16.7.5.4.9. Women’s Health

16.7.5.4.10. Vaccine Development

16.7.5.4.11. Others

16.7.5.5. South Africa Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

16.7.5.5.1. Pharmaceutical Companies

16.7.5.5.2. Biotechnology Companies

16.7.5.5.3. Medical Device Companies

16.7.5.5.4. Others

16.7.6. Rest of Middle East & Africa

16.7.6.1. Rest of Middle East & Africa Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

16.7.6.1.1. Clinical Monitoring and Trial Management

16.7.6.1.2. Data and Project Management

16.7.6.1.3. Medical Writing and Publishing

16.7.6.1.4. Regulatory Services

16.7.6.1.5. Patient Recruitment and Retention

16.7.6.1.6. Safety and Pharmacovigilance

16.7.6.1.7. Statistical Review and Reporting

16.7.6.1.8. Consulting Services

16.7.6.1.9. Others

16.7.6.2. Rest of Middle East & Africa Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

16.7.6.2.1. Planning and Discovery

16.7.6.2.2. Phase I

16.7.6.2.3. Phase II

16.7.6.2.4. Phase III

16.7.6.2.5. Phase IV

16.7.6.2.6. Post Launch

16.7.6.3. Rest of Middle East & Africa Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

16.7.6.3.1. Small and Medium Organizations

16.7.6.3.2. Large Organizations

16.7.6.4. Rest of Middle East & Africa Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

16.7.6.4.1. Cardiovascular

16.7.6.4.2. Oncology and Hematology

16.7.6.4.3. Infectious Diseases

16.7.6.4.4. Neurology

16.7.6.4.5. Rare Diseases

16.7.6.4.6. Respiratory

16.7.6.4.7. Urology

16.7.6.4.8. Cell and Gene Therapy

16.7.6.4.9. Women’s Health

16.7.6.4.10. Vaccine Development

16.7.6.4.11. Others

16.7.6.5. Rest of Middle East & Africa Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

16.7.6.5.1. Pharmaceutical Companies

16.7.6.5.2. Biotechnology Companies

16.7.6.5.3. Medical Device Companies

16.7.6.5.4. Others

16.8. Key Segment for Channeling Investments

16.8.1. By Country

16.8.2. By Services

16.8.3. By Development Phase

16.8.4. By Organization Size

16.8.5. By Therapeutic Areas

16.8.6. By End Users

17. Latin America Healthcare Contract Research Organizations Market Analysis and Forecasts, 2021 - 2029

17.1. Overview

17.1.1. Latin America Healthcare Contract Research Organizations Market Revenue (US$ Mn)

17.2. Latin America Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

17.2.1. Clinical Monitoring and Trial Management

17.2.2. Data and Project Management

17.2.3. Medical Writing and Publishing

17.2.4. Regulatory Services

17.2.5. Patient Recruitment and Retention

17.2.6. Safety and Pharmacovigilance

17.2.7. Statistical Review and Reporting

17.2.8. Consulting Services

17.2.9. Others

17.3. Latin America Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

17.3.1. Planning and Discovery

17.3.2. Phase I

17.3.3. Phase II

17.3.4. Phase III

17.3.5. Phase IV

17.3.6. Post Launch

17.4. Latin America Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

17.4.1. Small and Medium Organizations

17.4.2. Large Organizations

17.5. Latin America Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

17.5.1. Cardiovascular

17.5.2. Oncology and Hematology

17.5.3. Infectious Diseases

17.5.4. Neurology

17.5.5. Rare Diseases

17.5.6. Respiratory

17.5.7. Urology

17.5.8. Cell and Gene Therapy

17.5.9. Women’s Health

17.5.10. Vaccine Development

17.5.11. Others

17.6. Latin America Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

17.6.1. Pharmaceutical Companies

17.6.2. Biotechnology Companies

17.6.3. Medical Device Companies

17.6.4. Others

17.7. Latin America Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Country

17.7.1. Brazil

17.7.1.1. Brazil Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

17.7.1.1.1. Clinical Monitoring and Trial Management

17.7.1.1.2. Data and Project Management

17.7.1.1.3. Medical Writing and Publishing

17.7.1.1.4. Regulatory Services

17.7.1.1.5. Patient Recruitment and Retention

17.7.1.1.6. Safety and Pharmacovigilance

17.7.1.1.7. Statistical Review and Reporting

17.7.1.1.8. Consulting Services

17.7.1.1.9. Others

17.7.1.2. Brazil Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

17.7.1.2.1. Planning and Discovery

17.7.1.2.2. Phase I

17.7.1.2.3. Phase II

17.7.1.2.4. Phase III

17.7.1.2.5. Phase IV

17.7.1.2.6. Post Launch

17.7.1.3. Brazil Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

17.7.1.3.1. Small and Medium Organizations

17.7.1.3.2. Large Organizations

17.7.1.4. Brazil Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

17.7.1.4.1. Cardiovascular

17.7.1.4.2. Oncology and Hematology

17.7.1.4.3. Infectious Diseases

17.7.1.4.4. Neurology

17.7.1.4.5. Rare Diseases

17.7.1.4.6. Respiratory

17.7.1.4.7. Urology

17.7.1.4.8. Cell and Gene Therapy

17.7.1.4.9. Women’s Health

17.7.1.4.10. Vaccine Development

17.7.1.4.11. Others

17.7.1.5. Brazil Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

17.7.1.5.1. Pharmaceutical Companies

17.7.1.5.2. Biotechnology Companies

17.7.1.5.3. Medical Device Companies

17.7.1.5.4. Others

17.7.2. Argentina

17.7.2.1. Argentina Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

17.7.2.1.1. Clinical Monitoring and Trial Management

17.7.2.1.2. Data and Project Management

17.7.2.1.3. Medical Writing and Publishing

17.7.2.1.4. Regulatory Services

17.7.2.1.5. Patient Recruitment and Retention

17.7.2.1.6. Safety and Pharmacovigilance

17.7.2.1.7. Statistical Review and Reporting

17.7.2.1.8. Consulting Services

17.7.2.1.9. Others

17.7.2.2. Argentina Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

17.7.2.2.1. Planning and Discovery

17.7.2.2.2. Phase I

17.7.2.2.3. Phase II

17.7.2.2.4. Phase III

17.7.2.2.5. Phase IV

17.7.2.2.6. Post Launch

17.7.2.3. Argentina Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

17.7.2.3.1. Small and Medium Organizations

17.7.2.3.2. Large Organizations

17.7.2.4. Argentina Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

17.7.2.4.1. Cardiovascular

17.7.2.4.2. Oncology and Hematology

17.7.2.4.3. Infectious Diseases

17.7.2.4.4. Neurology

17.7.2.4.5. Rare Diseases

17.7.2.4.6. Respiratory

17.7.2.4.7. Urology

17.7.2.4.8. Cell and Gene Therapy

17.7.2.4.9. Women’s Health

17.7.2.4.10. Vaccine Development

17.7.2.4.11. Others

17.7.2.5. Argentina Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

17.7.2.5.1. Pharmaceutical Companies

17.7.2.5.2. Biotechnology Companies

17.7.2.5.3. Medical Device Companies

17.7.2.5.4. Others

17.7.3. Rest of Latin America

17.7.3.1. Rest of Latin America Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Services

17.7.3.1.1. Clinical Monitoring and Trial Management

17.7.3.1.2. Data and Project Management

17.7.3.1.3. Medical Writing and Publishing

17.7.3.1.4. Regulatory Services

17.7.3.1.5. Patient Recruitment and Retention

17.7.3.1.6. Safety and Pharmacovigilance

17.7.3.1.7. Statistical Review and Reporting

17.7.3.1.8. Consulting Services

17.7.3.1.9. Others

17.7.3.2. Rest of Latin America Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Development Phase

17.7.3.2.1. Planning and Discovery

17.7.3.2.2. Phase I

17.7.3.2.3. Phase II

17.7.3.2.4. Phase III

17.7.3.2.5. Phase IV

17.7.3.2.6. Post Launch

17.7.3.3. Rest of Latin America Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Organization Size

17.7.3.3.1. Small and Medium Organizations

17.7.3.3.2. Large Organizations

17.7.3.4. Rest of Latin America Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By Therapeutic Areas

17.7.3.4.1. Cardiovascular

17.7.3.4.2. Oncology and Hematology

17.7.3.4.3. Infectious Diseases

17.7.3.4.4. Neurology

17.7.3.4.5. Rare Diseases

17.7.3.4.6. Respiratory

17.7.3.4.7. Urology

17.7.3.4.8. Cell and Gene Therapy

17.7.3.4.9. Women’s Health

17.7.3.4.10. Vaccine Development

17.7.3.4.11. Others

17.7.3.5. Rest of Latin America Healthcare Contract Research Organizations Market Revenue (US$ Mn) and Forecasts, By End Users

17.7.3.5.1. Pharmaceutical Companies

17.7.3.5.2. Biotechnology Companies

17.7.3.5.3. Medical Device Companies

17.7.3.5.4. Others

17.8. Key Segment for Channeling Investments

17.8.1. By Country

17.8.2. By Services

17.8.3. By Development Phase

17.8.4. By Organization Size

17.8.5. By Therapeutic Areas

17.8.6. By End Users

18. Competitive Benchmarking

18.1. Market Share Analysis, 2020

18.2. Global Presence and Growth Strategies

18.2.1. Mergers and Acquisitions

18.2.2. Product Launches

18.2.3. Investments Trends

18.2.4. R&D Initiatives

19. Player Profiles

19.1. Advanced Clinical

19.1.1. Company Details

19.1.2. Company Overview

19.1.3. Product Offerings

19.1.4. Key Developments

19.1.5. Financial Analysis

19.1.6. SWOT Analysis

19.1.7. Business Strategies

19.2. BioAgile Therapeutics Pvt. Ltd.

19.2.1. Company Details

19.2.2. Company Overview

19.2.3. Product Offerings

19.2.4. Key Developments

19.2.5. Financial Analysis

19.2.6. SWOT Analysis

19.2.7. Business Strategies

19.3. Charles River Laboratories International, Inc.

19.3.1. Company Details

19.3.2. Company Overview

19.3.3. Product Offerings

19.3.4. Key Developments

19.3.5. Financial Analysis

19.3.6. SWOT Analysis

19.3.7. Business Strategies

19.4. Clinipace

19.4.1. Company Details

19.4.2. Company Overview

19.4.3. Product Offerings

19.4.4. Key Developments

19.4.5. Financial Analysis

19.4.6. SWOT Analysis

19.4.7. Business Strategies

19.5. CTI Clinical Trial & Consulting

19.5.1. Company Details

19.5.2. Company Overview

19.5.3. Product Offerings

19.5.4. Key Developments

19.5.5. Financial Analysis

19.5.6. SWOT Analysis

19.5.7. Business Strategies

19.6. Frontage Labs

19.6.1. Company Details

19.6.2. Company Overview

19.6.3. Product Offerings

19.6.4. Key Developments

19.6.5. Financial Analysis

19.6.6. SWOT Analysis

19.6.7. Business Strategies

19.7. ICON plc

19.7.1. Company Details

19.7.2. Company Overview

19.7.3. Product Offerings

19.7.4. Key Developments

19.7.5. Financial Analysis

19.7.6. SWOT Analysis

19.7.7. Business Strategies

19.8. IQVIA Inc.

19.8.1. Company Details

19.8.2. Company Overview

19.8.3. Product Offerings

19.8.4. Key Developments

19.8.5. Financial Analysis

19.8.6. SWOT Analysis

19.8.7. Business Strategies

19.9. Parexel International Corporation

19.9.1. Company Details

19.9.2. Company Overview

19.9.3. Product Offerings

19.9.4. Key Developments

19.9.5. Financial Analysis

19.9.6. SWOT Analysis

19.9.7. Business Strategies

19.10. Syneos Health

19.10.1. Company Details

19.10.2. Company Overview

19.10.3. Product Offerings

19.10.4. Key Developments

19.10.5. Financial Analysis

19.10.6. SWOT Analysis

19.10.7. Business Strategies

19.11. Thermo Fisher Scientific Inc.

19.11.1. Company Details

19.11.2. Company Overview

19.11.3. Product Offerings

19.11.4. Key Developments

19.11.5. Financial Analysis

19.11.6. SWOT Analysis

19.11.7. Business Strategies

19.12. Worldwide Clinical Trials

19.12.1. Company Details

19.12.2. Company Overview

19.12.3. Product Offerings

19.12.4. Key Developments

19.12.5. Financial Analysis

19.12.6. SWOT Analysis

19.12.7. Business Strategies

19.13. WuXi AppTec

19.13.1. Company Details

19.13.2. Company Overview

19.13.3. Product Offerings

19.13.4. Key Developments

19.13.5. Financial Analysis

19.13.6. SWOT Analysis

19.13.7. Business Strategies

19.14. Other Market Participants

20. Key Findings

At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.

Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.

Prominent participants in our primary research process include:

Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
Research and development participants, distributors/suppliers and subject matter experts

Secondary Research includes data extracted from paid data sources:

Reuters
Factiva
Bloomberg
One Source
Hoovers

Research Methodology

Key Inclusions

Request A Sample

Ask for Discount

Enquiry Before Buying

Request For Customization

Purchase Options

Single users $4600

Multi users $8200

Global users $9100

Buy Now

Reach to us

Call us on

+91-74002-42424

Drop us an email at

sales@absolutemarketsinsights.com